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ABSTRACT 
Robert Todd Erickson: Assessment of Phantom Dosimetry and Image Quality of Accuitomo 
170 and MiniCAT Cone-Beam Computed Tomography 
(Under the direction of John B. Ludlow) 
Introduction: Escalating use of cone-beam computed tomography contributes to a 
burgeoning public health issue regarding the amount of ionizing radiation associated with 
diagnostic imaging delivered to the population, especially children.  
Methods: Effective doses were calculated and compared from optically stimulated 
dosimeter measurements and a previously validated protocol using anthropomorphic adult 
and child phantoms scanned with the Accuitomo 170 (J. Morita, Japan) and MiniCAT 
(Xoran Technologies, Ann Arbor, MI) CBCT machines. 
Results: Average child phantom doses (440 and 117 µSv) were 60% and 56% greater 
than the adult doses from the Accuitomo 170 and MiniCAT units respectively.  Thyroid dose, 
particularly to the child, had a significant contribution to the overall dose. 
Conclusion: Effective dose for the two units increased as FOV increased.  The child 
dose, especially the thyroid, increased when compared to the adult phantom.  Child protocols 
and the smallest FOV helps reduce the child’s effective dose. 
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CHAPTER 1. LITERATURE REVIEW 
Cone-beam Computed Tomography Imaging 
The field of radiology had its genesis in late 1895, when Wilhelm Roentgen 
fortuitously discovered x-rays while working in his physics lab in Germany. Roentgen 
quickly recognized the value of his discovery to medicine and within a very short time 
produced and published the first medical x-ray image in early 1896. The discovery of x-rays 
was followed by significant scientific vigor and further research and additional properties 
were learned. Some facts revealed that x-rays had an insidious characteristic that could cause 
extensive tissue damage and even death. The famous American inventor Thomas Edison was 
investigating various properties of x-rays with an assistant and long-time friend, who 
subsequently suffered severe radiation burns that lead to tremendous suffering and his death 
a few years later. This occurred because x-rays are located in the high-energy spectrum of 
electromagnetic radiation. X-rays can penetrate as well as interact with tissues in their path. 
Absorption and scattering of this high-energy radiation is what reaches an x-ray receptor and 
ultimately results in an image. A Boston dentist made a significant discovery regarding the 
spectrum of energy in an x-ray beam when he used x-rays to image teeth. He learned that by 
restricting the x-ray beam with a sheet of lead with a hole in the center and inserting a leather 
or aluminum filter into the hole he improved the diagnostic quality of the radiographs. This 
property of x-rays heralded the quest to understand and manipulate the complex relationship 
between dose and image quality.
1 
 
2 
Over the past nearly 120 years, the field of radiology has made huge strides with 
technological advancements that have subsequently resulted in remarkable contributions to 
the diagnosis and treatment of disease in all fields of health care. Different types of medical 
images can be made by varying the types of energies and the acquisition technology 
employed. In its simplest form radiography is accomplished with an x-ray source on one side 
of the patient and a typically flat x-ray detector on the other side. A short-duration pulse of x-
rays is emitted by the x-ray tube, and a large percentage of x-rays in the beam interact with 
the patient and are preferentially attenuated due to the varying tissue densities. Some x-rays 
reach a detector and, depending on the technology being used, will produce an image of 
varying likeness and resolution to the region being scanned.
2  
One of the most significant landmark developments in image acquisition was the 
invention of a revolutionary imaging technique in 1972 by Godfrey Hounsfield, a British 
engineer/physicist, that used image reconstruction mathematics developed by Alan Cormack 
in the 1950s and 1960s to produce cross-sectional images of the head.
3 
This modality has 
become known as computed tomography (CT). Although initially slow with rudimentary 
image quality, CT has undergone several generations of technological advancements over the 
past four decades. The improvements have reduced scan time, increased x-ray tube power, 
and advanced reconstruction algorithms, which have led to significant enhancements in CT 
image quality and ease of use.
2. 
Due to the escalations in image quality and reduction in 
acquisition time, CT has experienced gigantic growth since its inception. The advent of 
helical CT scanners in 1989 and then multi-slice CT in 1998 has led to a pronounced boom in 
usage. Reducing scan time increases the number of clinical applications for CT imaging and 
also means that one scanner can image more patients per day. Most reports indicate the 
3 
number of CT scans performed annually in the United States is between 70 million and 80 
million. Between 1997 and 2007, there has been an exponential growth rate for CT scanning 
that shows no sign of abatement in the near future.
2 
Newer Imaging Modalities 
CT scanners function with the x-ray source emitting a fan-shaped beam of radiation 
that encircles the patient 360°
 
as the patient is moved through a gantry. For a specified region 
of interest (ROI), modified axial or helical slices of a predetermined width using collimation 
are captured by an array of detectors. The raw data captured in each projection by the 
detector is stored in a computer. With CT imaging systems, the x-rays form a stored 
electronic image that is displayed as a matrix of intensities. Image reconstruction occurs via a 
complex process called filtered back projection and Feldkamp reconstruction. The CT 
imaging system will often use an array processor and completes several hundred thousand 
calculations simultaneously. Three-dimensional multiplanar reconstruction (MPR) images 
can be viewed in axial, coronal, or sagittal planes or in a custom plane depending on the 
diagnostic task desired.
1
 
The type of CT imaging used for this project is a relatively recent technology most 
commonly referred to as cone-beam computed tomography (CBCT). The equipment has 
many comparisons to conventional CT, but it is the differences that have made this modality 
gain tremendous popularity, particularly for maxillofacial imaging. CBCT was initially 
developed for angiography in 1982. More contemporary medical applications have included 
radiotherapy guidance,
4
 mammography,
5
 and cardiology.
6 
CBCT is the imaging modality used in this research study. Therefore, an overview of 
the technology being tested and scrutinized will be provided. The information will aid in 
4 
obtaining an understanding of the influence of technical parameters on image quality and 
patient radiation exposure. It is vital to understand that there are similarities between CBCT 
and Multi-Slice Computed Tomography (MSCT), which is used ubiquitously in hospitals and 
medical centers throughout the developed world. However, the unique characteristics of the 
CBCT have both lead to its escalating use in maxillofacial imaging, as well as inherently 
limited the depth and spectrum of its usage. 
Imaging data for CBCT is acquired by using an x-ray source and a detector mounted 
on a rotating gantry that moves synchronously around the region of interest. The radiation 
emitted from the x-ray tube passes through circular collimation, which produces a three-
dimensional divergent pyramidal beam or “cone beam.” This beam revolves 180° to 360° 
around the patient, passing through the middle of the area of interest onto a two-dimensional 
digital array, which serves as an area detector. The exposure incorporates the entire region of 
interest; therefore, the full volume of tissue is captured with one rotation of the gantry. 
During this rotation, between 150 and 600 (depending on the unit) sequential planar 
projection images of the selected field-of-view (FOV) are acquired. The individual images 
are similar to 2D lateral and posterior- anterior (PA) cephalometric images that have been 
sequentially offset from each other during the rotation of the gantry. This process differs 
from Multi-Detector CT (MDCT), which uses a fan-shaped beam in a spiral progression 
through a region of interest acquiring individual image slices that are then stacked to provide 
a 3D representation. 
The single projection or set of basis images produced as the result of photons being 
attenuated by the tissue in the ROI reach the receptor and constitute the “raw data.” During 
the rotational arc of 180°—360°, the several hundred exposures formulate a volume that has 
5 
enough data to be calculated and reconstructed to form a visual image. Complex software 
programs with sophisticated algorithms incorporating filtered back projection have been 
created to provide primary reconstruction images in three orthogonal planes (axial, sagittal, 
and coronal). Custom sections can also be constructed using numerous software programs 
available for viewing the images. 
Factors Effecting Image Quality and Patient Dose 
There are many factors that complement or compromise the final quality of a 
radiographic image and the dose of ionizing radiation received by the patient. The end 
product is a result of the interplay between a long list of variables that comprise the imaging 
protocol. In any form of imaging examination, keeping the patient immobile is essential to 
provide data with little or no motion artifacts. CBCT machines are different than MDCT 
machines. They are of smaller dimension than MDCT units, which place the patient secured 
in a supine position on a specialized exam table that moves through the gantry, and the 
design allows the patient to stand or be comfortably seated. A variety of head restraints, chin 
rests, and bite indices become critical to stabilize the patient, particularly children and the 
disabled, injured, or elderly to minimize movement. 
The manner in which the x-rays are delivered to the patient can have a significant 
impact on the exposure a patient receives. Delivering the least amount of radiation dose to 
the patient is a fundamental tenet of responsible imaging practices. The ALARA (As Low As 
Reasonably Achievable) principle has been promoted for many years in the field of 
radiology. It essentially dictates that acquisition of the image be performed with appropriate 
selection of exposure factors and an imaging protocol that minimizes the dose to the patient 
while maintaining adequate image quality. The importance of abiding by the ALARA 
6 
principle has trickled into the mindset of the manufacturers. CBCT machines are being built 
with x-ray generation that is pulsed to coincide with detector activation and sampling rather 
than generating a continuous beam. This alone will permit up to 50% reduction in exposure 
time to the patient, which reduces the radiation dose. More CBCT machines are being 
manufactured with this capability, in part, because of the industry response to the initiative to 
rein in exposure and harmful effects to patients.  
Other factors that affect patient dose are tube current (mA), tube voltage (kVp), and 
time (s). These settings are often fixed on CBCT units, but newer technology is also 
incorporating scout views and exposure control feedback mechanisms to help limit exposure. 
More will be said about this later in the paper.  
Scan Volume  
Field of view (FOV) and number of basis images need to be taken into account in the 
effort to reduce the dose to the patient, particularly children or adolescents, who are much 
more susceptible to the stochastic effects of radiation over a lifetime.
3
 Scan volume or (FOV) 
plays pivotal role in determining the amount of radiation delivered. Initially, the CBCT 
machines had only one or a few choices available to capture the region of interest, many 
times incorporating much more volume of tissue than actually necessary. The more 
contemporary machines are being designed with more latitude for both selection of FOV 
(small, medium, large, or specific sizes such as 5 x 5 cm, 8 x 8 cm, 6 x 12 cm, 10 x 10 cm, 
etc.) and for tube amperage (mA) (i.e., High Definition, Standard, Fast Scan). These 
parameters allow refinement and individualization to fulfill the needs of the practitioner and 
ensure the safety of the patient.  
7 
There are additional components of CBCT that make it unique. Appropriate use of 
these functions will assist with compliance of the ALARA principle. These are the selection 
of the number of images acquired per second by the detector (frame rate), the arc rotation 
(180°–360°), and the rotation speed of the synchronously moving x-ray source and detector. 
These factors will determine the number of basis images that will play a role in patient 
exposure. Some of the newer CBCT units are configured so a pre-set number of basis images 
are obtained based on the type of image requested. There are positive and negative 
ramifications to adjustment of these variables. Higher frame rates increase the signal-to-noise 
ratio, which produces images with less noise and fewer artifacts. Of course, this comes at a 
cost to the patient with more exposure to ionizing radiation. Also, the time necessary for 
reconstruction is longer. Decreasing the scan times by increasing the frame rate is more 
desirable because it reduces the likelihood of patient movement and the subsequent decrease 
of image quality. 
Detectors 
There are two basic groups of image detectors used by CBCT machines—the older 
image intensifier tube/charge-coupled device (II/CCD) and or the newer, more widespread 
but expensive flat panel detector (FPD). FPD’s are either direct or indirect detectors. The 
direct route uses a photoconductor material, selenium, which is a more efficient absorber of 
x-rays. The electrons released are sent “directly” to a thin-film transistor and an electrical 
signal is generated. An “indirect” detector uses the scintillating material cesium iodide, 
which converts x-ray energy into light. The light energy is converted into electrical energy 
proportional to the x-ray exposure and sent to the thin-film transistor in the detector. FPD’s 
8 
are very expensive as they get larger. To keep the cost of the CBCT more manageable, the 
FPD will be limited in size. 
With CT imaging systems, the x-rays form a stored electronic image that is displayed 
as a matrix of intensities. The matrices can be different sizes. Most are 512 x 512, which 
represents 262,144 cells of information. Some are 1024 x 1024, which is an incredible 
1,048,576 individual cells. Therefore, the detector can have the same physical dimensions but 
contain four times the number specific data points that will comprise the image. Generally, 
the image produced from more pixels leads to better resolution.  
Each cell of information is a 2D pixel (picture element). When multiplied by the 
thickness dimension it becomes a 3D voxel (volume element). A unique characteristic of 
CBCT is that the voxels are isotropic (each 2D square is the same dimension), unlike the 
MDCT, which has anisotropic (unequal sides) voxels. The voxel size is determined by 
multiplying the pixel size by the thickness of the CT slice. The precise CT number of any 
given pixel is related to the x-ray attenuation coefficient of the tissue contained in the voxel. 
For CBCT, each pixel is assigned a brightness number that represents a specific location in 
the matrix. MDCT pixels also each contain exclusive information. This data is referred to as 
the CT number or Hounsfield unit (HU) (-1000 to +3000). The HU is a discrete value 
allowing image quality to be easier to characterize and quantitate. The particular value will 
be identical in all MDCT images. There has been an attempt to correlate CBCT brightness 
values with Hounsfield units; however, it is controversial has not been shown to be accurate.
7 
In regards to the relationship between pixel size and exposure, detectors with smaller 
pixels capture fewer x-ray photons per voxel, which results in a noisier image. To overcome 
9 
this effect and gain higher resolution, greater doses of radiation are necessary. Again, this 
demonstrates the compromise between image quality and patient exposure. 
Grayscale 
Grayscale is the ability of the CBCT image to display subtle contrast differences in 
attenuation of the x-ray beam by the detector. This parameter is defined as the bit depth of 
the system, which determines the number of shades of gray that can be displayed. 
Contemporary CBCT machines use detectors capable of presenting 12 bits or more. For 
example, a 12-bit detector is capable of displaying 2
12
,
 
or 4096, shades of gray and a 16-bit 
can exhibit 65,536 shades of gray. Interestingly, initial observations proposed that the human 
eye could distinguish only 30 to 50 shades of gray.
8,9
 It is now established that the human eye 
can discriminate ‘between 700 and 900 simultaneous shades of gray for the available 
luminance range of current medical displays and in optimal conditions.
10
  
Reconstruction 
Once information from the basis projection frames has been received by the detector 
and sent to the computer, the next process is to create a volumetric data set. This procedure is 
referred to as primary reconstruction. As previously stated, a single rotation around the 
patient (180°–360°) is all that occurs with CBCT and is relatively quick (12–20 sec). What 
happens next with this data is quite complex and could not occur until the 1990’s, when 
inexpensive, more powerful computers were available to process the massive amount of 
acquired image data. For example, approximately 100 to more than 600 individual basis 
images, each with more than 1 million pixels and 12 to 16 bits of data assigned, need to be 
processed. This presents a colossal task that has to be performed in a matter of seconds and 
can only be performed by a computer.  
10 
Reconstruction times vary depending on the acquisition parameters (voxel size, FOV, 
and number of projections), the speed of the hardware, and the sophistication of the software. 
A series of computationally complex software algorithms process the data and create a 
volumetric data set composed of individual cuboidal voxels by a process termed 
reconstruction. Subsequently, secondary reconstruction allows sectioning of the volumetric 
data into orthogonal images (axial, sagittal, and coronal) to finally be visualized on a screen 
and evaluated by the clinician.
3
 
Three-Dimensional Volume Rendering 
Because CBCT systems have been developed for the maxillofacial region, there has 
been an interest in 3D reconstruction. Many devices are capable of large FOV imaging of the 
skull.
11  
Dose measurements in micro-Sieverts (µSv) and time measured in seconds (s) or 
milliseconds (ms) have been suggested to be of the same order of magnitude as other dental 
radiographic modalities.
12
 Volume rendering refers to techniques in computer graphics that 
are used to project a 3D discretely sampled data set to display a 2D projection. There are two 
approaches:  Direct Volume Rendering (DVR) and Indirect Volume Rendering (IVR). IVR is 
the oldest and requires huge amounts of pre-processing on the dataset. A pre-selection of the 
intensity of the grayscale to be displayed throughout the entire dataset is required. This 
requires special software and powerful computers that perform complex calculations. 
Sensitivity to noise with introduction of errors can be a problem. Ultimately, IVR provides a 
volumetric surface rendering with depth, allowing the image to display objects of interest 
such as the soft tissue surface, bone, and teeth. This is often referred to as segmentation. 
DVR is the most popular and simple method of 3D reconstruction. Maximum 
intensity projection (MIP) is the most common procedure, which produces a “pseudo-”3D 
11 
image.
13 
MIP consists of projecting the voxel with the highest attenuation value along a 
straight line on every view traced from the expected position of the operator throughout the 
volume onto a 3D image.
14
 Such an algorithm is rather simple; for each x, y coordinate only 
the pixel with the highest CT number along the z-axis is represented. In a bi-dimensional 
image all dense structures in a given volume are observed. For example, it is possible to find 
all the hyper-dense structures in a volume independent of their position. This method tends to 
display bone, a contrast-filled structure, preferentially. Lower attenuation structures are not 
well visualized.
15
 Contrast has not been used in maxillofacial imaging for dental purposes 
other than to visualize gland parenchyma in sialography with CBCT.  Additional applications 
may become available in the future.  
Surface rendering using special algorithms has initiated a new application related to 
data processing that is being used in dentistry, particularly in orthodontics and oral and 
maxillofacial surgery applications. In surface rendering, the voxels located on the edge of a 
structure are identified, usually by intensity thresholding, and sometimes enhanced with 
morphologic filtering, and these voxels are displayed. The remaining voxels in the image are 
usually invisible. The thresholding assignment of the voxels that will be visible is both 
critical and sometimes difficult to reproducibly define. If the thresholding process is too 
aggressive, actual protruding structures can be lost from view because of partial-volume 
effects. If the thresholding process is too lax, non-tissue materials (fluids) can be rendered as 
if they were tissue, causing inaccuracies in the image.
15
 The presence of exo-mass effects 
occur when there is a mass outside the FOV.  This effect lowers the measured CT number 
rapidly at the scan edge furthest from the exo-mass and raises it on the adjacent edge.  Since 
12 
there are no CT numbers in CBCT, this process can affect the gray value display of bone in 
different areas of the volume.
45 
Accuracy 
The institution of maxillofacial CBCT machines provides practitioners with the 
ability to easily generate 3D volumetric renderings using relatively inexpensive third-party 
computer-based software. This becomes a wonderful picture on the computer screen, but can 
the data actually provide useful information that will aid in treatment of patients? One of the 
primary questions to answer is: Are the 3D reconstruction images dimensionally accurate 
with the original subject, the patient? A great number of researchers set out to determine the 
answer and numerous papers were published. The overall consensus indicated that CBCT 
measurements could be used for quantitative analysis. The CBCT measurements compared 
with the anatomic truth were highly reliable.
16,17,18,19  
Researchers wrote that “many linear measurements between cephalometric landmarks 
on 3D volumetric surface renderings using Dolphin 3D software generated from CBCT 
datasets may be statistically significantly different from anatomic dimensions, most can be 
considered to be sufficiently clinically accurate for craniofacial analysis.”20 Although there 
were errors in the linear measurements, they were often not significant. “For well-defined 
points, measurement accuracy was expressed by average errors less than 1.2% for two-
dimensional measurement techniques and less than 0.6% for three-dimensional measurement 
techniques. Average errors from 0.2 mm to 2.1 mm are in line with errors reported for both 
conventional and cone beam CT.”21  
  
13 
Imaging Protocol 
An imaging protocol is a customary set of technical exposure parameters for CBCT 
imaging that depend on the particular purpose of the examination. It is developed to provide 
images of premium quality with the least amount of radiation exposure to the patient. 
Ordinarily, the CBCT manufacturer will have fixed, pre-set protocols that are automatic 
based on the imaging field, number of basis images, and voxel resolution.
3  
Exposure settings of tube voltage (kVp) and tube current (mA) will affect the quality 
and quantity of the x-ray beam. The manufacturer most often will have these parameters 
fixed as well. In the event that there are operator-adjustable exposure settings, it is mandatory 
that the operator have command of the working knowledge of how the image quality and 
eventual patient dosage will be impacted by these settings. Because this is often not likely, it 
is best that the units have default settings that lead to better compliance with the ALARA 
principle. 
Image Optimization 
Most software programs for CBCT provide the user with resources to adjust contrast, 
brightness, and edge sharpening. To aid the system to present the best image to the clinician 
and assist with an accurate diagnosis, there are controls available to adjust brightness (level) 
and contrast (window) parameters to selectively favor bony tissue. This is analogous to the 
window and leveling functions in conventional CT to facilitate viewing a ‘bone window” or a 
“soft tissue window.” Unlike conventional CT, there is pronounced variability between 
different CBCT units depending on how the machine was manufactured and the proprietary 
software pre-set parameters employed. Medical imaging benefits more from increased 
contrast and sharpness. The key is enhancing the image without spoiling it. When images are 
14 
processed for visual interpretation, viewers are the ultimate judge of how well a specific 
method work.
22 
Application of sharpening, filtering, and edge algorithms is encouraged. Edge 
enhancement is the accentuation of the interface between different tissues. This controls the 
extent to which the contrast in the edge detected is enhanced. Subtle detail is not improved 
but imperfections from noise, for example, are diminished. Some image data are lost as part 
of this process. Edge enhancement is only capable of improving the perceived sharpness of 
an image.
23 
 
Spatial Resolution 
The image quality on a medical image is related to how well it reproduces and 
represents anatomical or functional information to the interpreting practitioner, allowing an 
accurate diagnosis. Radiological images acquired using ionizing radiation can usually be 
enhanced by increasing the radiation dose. The dose to the patient then becomes a potential 
health safety issue. Therefore, diagnostic radiographic images require a number of important 
compromises in which image quality is not completely maximized but is reasonably 
optimized to successfully execute the diagnostic assignment ordered.  
Spatial resolution designates the level of detail that can be seen by the human eye in 
an image. Basically, the limiting spatial resolution relates to how small of an object can be 
seen on an individual imaging system. Measurements of spatial resolution are generally 
performed at high doses of x-rays, so there is low noise and issues of quantum mottle are 
excluded as a reason for poor resolution. The preponderance of imaging systems in radiology 
are now digital. The size of the pixel is a limiting factor in an image and establishes a 
boundary on what can theoretically be resolved in a particular image. It is typically not 
possible to resolve an entity that is smaller than the individual pixel size. Furthermore, 
15 
although images with smaller pixels have the potential to convey increased spatial resolution, 
there are many additional dynamics that affect spatial resolution. In many cases, it is actually 
not the pixel size that limits spatial resolution.
2 
Additional factors including the number of 
basis images, reconstruction algorithm, focal spot size, the fraction of the pixel’s area capable 
of collecting light (fill factor), detector motion blur, internal patient scatter, and beam 
geometry affect the spatial resolution of an image. The focal spot size and the geometric 
configuration of the x-ray source determine the amount of blur or lack of sharpness in the 
image. A smaller focal spot leads to less image blur and better spatial resolution. X-ray tubes 
that produce smaller focal spots are considerably more expensive and will therefore be 
limited to allow the CBCT machine to remain cost effective.
3  
Image Artifacts of CBCT 
An imaging system that perfectly presents the structures within the region of interest 
without distortion has not been developed yet. To one degree or another, there are artifacts in 
all of the images produced by our radiographic equipment. In general, an “artifact” is “a 
distortion or error in an image that is unrelated to the subject being studied.”24 A CT image 
artifact is defined as “any discrepancy between the reconstructed CT numbers in the image 
and the true attenuation coefficients of the object.”25 This definition is comprehensive and 
implies that anything that causes an incorrect measurement of transmission readings by the 
detectors will result in an image artifact. Because CT numbers represent gray shades in the 
image, incorrect measurements will produce incorrect CT numbers that do not represent the 
attenuation coefficients of the object.
26 
Artifacts can degrade image quality, affect the 
perceptibility of detail, or even lead to misdiagnosis. This can cause serious problems for the 
patient, radiologist, and surgeon/provider in the event of an improper diagnosis. 
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CBCT images inherently have more artifacts than MDCT images for a number of 
reasons. CBCT machines use a lower energy spectrum, have the cone-beam–shape geometry, 
produce aliasing artifacts caused by the cone-beam divergence and scatter, and commonly 
contain a higher noise level.  
Artifacts can be arranged into categories of inherent artifacts: procedure-related 
artifacts, introduced artifacts, and patient motion artifacts. Inherent artifacts are a result of 
limitations in the physical processes involved in the acquisition of CBCT data. There are also 
three types of cone-beam–related artifacts under this category: scatter, partial volume 
averaging, and cone-beam effect.  
Scatter is a fundamental phenomenon associated with the interaction between x-ray 
photons and matter. Scatter radiation is comprised of photons that have been diffracted from 
their original straight-line trajectory by interactions with tissue/material. These photons can 
interact, which results in a change in direction multiple times prior to reaching the detector. 
Or they may exit the patient and never reach the detector. They provide useless information 
and degrade the image quality. Scatter is reduced in MDCT by post-patient collimation 
placed in front of the detector and special algorithms. This cannot be done in CBCT because 
of the unique pyramidal-shaped beam and the use of area detectors. Scatter increases with 
increased field size. Scatter-induced artifacts in CBCT are only slightly diminished using 
processing algorithms. The images, therefore, are characterized by a lower signal-to-noise 
ratio than MDCT and have poor soft tissue contrast.  
Partial-volume averaging is a feature of both MDCT and CBCT. This occurs when 
the voxel size of the detector contains two or more tissue types of the subject being imaged. 
Each tissue may have a slightly different linear attenuation coefficient. The calculation 
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performed by the computer will then be an average of the CT numbers of the tissue covered 
in the voxel. If the CT numbers are close together (i.e., +43 gray matter, +40 blood, and +46 
white matter), then the CT number reported for that voxel will be an average that is 
reasonably close to the actual tissue. This is known as partial-volume averaging.
26 
If the 
voxel contains tissues that are significantly different (i.e., + 35 muscle, -75 fat, +850 bone) 
then the mathematical calculation to determine the single CT number that will represent the 
voxel will be significantly different from the actual tissue. This leads to partial-volume 
artifacts, which are very inaccurate and appear as bands or streaks in the image.
27 
Selection 
of the smallest voxel size will help reduce the presence of these effects. In MDCT, selection 
of thinner slices will also diminish these effects. 
Cone-beam effect occurs particularly in the peripheral portions of the scan volume. 
Because of the divergence of the x-ray beam as it rotates around the patient, structures at the 
bottom of the image field are exposed only when the x-ray source is on the opposite side of 
the patient.
3 
The use of a large cone angle can lead to significant artifacts. Some MDCT units 
use a small cone-shaped beam as opposed to strictly a fan beam and will also obtain artifacts. 
The result is image distortion, streaking artifacts, and greater noise from what amounts to 
under-sampling. This effect is minimized by incorporation of various forms of cone-beam 
reconstruction by the manufactures. 
Procedure-related artifacts are another type of artifact that can follow as a result of the 
acquisition process. Under-sampling of the object being imaged can occur when too few 
basis images are obtained for image reconstruction or when rotation trajectory arcs are 
insufficient. The reduced data sample leads to mis-registration, sharp edges, and noisier 
images as a result of aliasing, which appear as fine striations in the image. A Moire artifact 
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occurs when too great an interval between basis projections (under-sampling) or an 
incomplete scanning trajectory results in improper recording of data by the reconstruction 
software. On the CBCT image, particularly on the periphery, fine alternating hyper-dense 
and hypo-dense stripes appear to be radiating from the edge of the volumetric data. This can 
be reduced by increasing the number of basis images. However, the dose to the patient 
becomes greater so a compromise much be reached. 
Scanner-related artifacts appear as circular or ring streaks resulting from deficiencies 
in scanner detection or poor calibration. Both of these problems result in a consistently 
repetitive reading at each angular position of the detector, resulting in a circular artifact. 
Misalignment of the x-ray source to the detector creates a double contour artifact, 
similar to that created by patient motion. Repeated use of CBCT equipment over time may 
result in slight configuration changes, and components may need to be periodically 
realigned.
3 
 
Noise-induced artifacts are an important issue when selecting the exposure 
techniques. Noise is influenced partially by the number of photons that strike the detector. 
More photons mean less noise and a stronger detector signal, whereas fewer photons result in 
more noise and a lower detector signal. One can be over-judicious with trying to deliver the 
least amount of radiation possible and actually cause photon starvation. Photon starvation can 
ensue with poor patient positioning in the FOV, causing the object to be improperly scanned. 
Also, unsuitable selection of exposure factors (kVp, mA, time), scan speed, and inadequate 
tube power can lead to photon starvation, which often leads to severe streak artifacts.  
  
19 
Introduced Artifacts 
When an x-ray beam passes through an object being imaged, the lower energy 
photons are preferentially absorbed by the material and the higher energy rays pass through 
the substance to the detector. This phenomenon is referred to as beam hardening. Standard 
filtered-back projection reconstruction algorithms do not fully address the polyenergetic 
nature of the x-ray spectrum used in CT. X-rays that pass through a large amount of dense 
tissue, such as the petrous portion of the temporal bone, teeth, etc., have a high degree of 
attenuation and cause the x-ray beam to become “hardened.” A hard x-ray beam refers to a 
beam whose average spectrum of energies is higher than the original beam when it left the 
source prior to interacting with the patient. The presence of dense (higher z) structures such 
as bone in the x-ray path cause the lower energy portion of the beam to be preferentially 
attenuated compared to the higher energy photons. The beam undergoes an upward shift in 
average x-ray energy as it passes through more dense material like bone.
2 
 
To reduce some of the beam hardening effects in CT, the beam can be pre-hardened 
by adding a filter comprised of thicknesses of aluminum, for example. However, beam 
hardening can still occur, especially when dense structures such as metal exist in the field. 
The x-ray beam that corresponds to the path that intersects the metal becomes exceptionally 
hardened and appears as a streak in the image. The dark, angular artifacts that result appear 
as webbing due to the CT scan geometry. Metallic restorations in teeth, dental implants, 
metal surgical clips, titanium reconstruction plates, and bullet fragments will all cause streak 
artifacts to a certain degree. In clinical practice, methods to lessen streak artifacts would be to 
reduce the field size, modify patient position, and separate the dental arches to avoid 
scanning regions susceptible to beam hardening. It is also important to have the patient 
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remove any jewelry prior to scanning to eliminate overlay of the object over the desired 
anatomy of interest and also to reduce peripheral beam hardening effects and scatter 
superimposed on the region of interest.
3 
 
Strengths and Limitations of CBCT 
Many of the qualities of CBCT that have been mentioned make CBCT a very suitable 
imaging system over conventional CT for routine usage in the dental office. There are also 
limitations to its use. CBCT offers significantly reduced physical dimensions compared to 
conventional CT and a cost that is approximately one-fifth the price.
3 
 
CBCT offers fast acquisition with utilization of advanced solid-state detectors and 
fast frame rates, increased computer processing speed, and many units integrating reduced 
arc trajectory. The majority of CBCT scanning can be performed in 30 seconds or less.
3 
 
All CBCT machines presently use megapixel solid-state equipment for x-ray 
detection, which provide sub-millimeter voxel resolution in all orthogonal planes. There are a 
few CBCT units capable of high resolution imaging (.076–0.125 mm voxel resolution), 
which is necessary to distinguish fine detail in structures such as root canal morphology or 
root fractures in dentistry.
3 
Relatively Low Patient Radiation Dose 
As was previously discussed, the ultimate radiation dose delivered to the patient is of 
utmost importance. Published reports indicate that the effective dose (ICRP 2007) for various 
CBCT machines ranges from 25 to 1025 µSv, depending on the manufacturer, model, FOV, 
and imaging protocol employed. These readings are approximately equal to 1 to 42 digital 
dental panoramic radiographs (~24 µSv) or 3 to 123 days’ equivalent per capita natural 
background radiation (~300 µSv in the United States).28 Patient radiation dose can be reduced 
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by beam collimation, number of basis images, exposure factors, and protective shielding. 
CBCT imaging affords a breadth of patient dose reduction compared with head MDCT 
imaging, which can be in the range of 430 to 1160 µSv.3  
Interactive Analysis 
CBCT use is not only very easy for a clinical office environment, it is also very user 
friendly to view and analyze the images. Data reconstruction and viewing is performed via a 
personal computer. Furthermore, some manufactures provide in-depth software that allows 
for specific tasks and cursor driven measurements for determining accurate positioning and 
precise dimensions for dental implant placement, bone grafting, orthodontic work-up and 
mid-treatment analysis, endodontic procedures, and oral surgical requirements. The locations 
and sites can be annotated and labeled for future reference and discussion with patients and 
other practitioners. 
Limitations 
With any radiographic imaging system there are limitations. None of the devices are 
perfect. The cone-beam projection acquisition geometry leads to a large volume of tissue 
being irradiated with each basis image. A large portion of the photons undergo Compton 
interactions and produce scattering. The scattered radiation occurs in all directions and can 
exit the patient or reach the pixels in the area detector from a pathway unrelated to the 
direction the photon was originally traveling. Many of the photons have enough energy to 
permit them to be scattered many times by multiple atoms. Ultimately, this results in 
information generated in the pixel that is useless because it does not correlate with a 
corresponding linear attenuation coefficient value that is representative of the tissue. The CT 
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number or value has been adulterated by this process and is useless information, referred to 
as noise.
29 
There are three major sources that contribute to noise in an image. The first source is 
the quantum noise determined by the x-ray flux or the number of detected x-ray photons. It is 
influenced by the scanning techniques (i.e., x-ray tube voltage, tube current, slice thickness, 
and scan speed), the scanner efficiency (e.g., detector quantum efficiency), and the patient 
(e.g., patient size, amount of bone and soft tissue in the scanning plane). The scanning 
technique dictates the number of photons that reach the patient, and the scanner efficiency 
determines the percentage of the x-ray photons exiting the patient converted to useful 
signals.
26 
Also, because of the enlarged divergence of the x-ray beam over the area detector, 
there is a pronounced heel effect. The x-rays that constitute the useful beam emitted toward 
the anode side must traverse a greater thickness of target material than the x-rays emitted 
toward the cathode direction. The intensity of x-rays that are emitted through the “heel” of 
the target is reduced because they have a longer path through the target and therefore 
increased absorption. The difference in radiation intensity across the width of the useful 
beam of an x-ray field vary as much as 45%.
1  
The second source that influences the noise performance is the inherent physical 
limitations of the system. These include the electronic noise in the detector photodiode, the 
electronic noise in the data acquisition system, scatter radiation, and other factors beyond the 
scope of this paper. Electronic noise is due to the inherent degradations of the detector 
system related to the x-ray absorption efficiency of the detector.
26 
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Reconstruction Algorithms 
The third noise-influencing factor is the reconstruction parameters. Image 
reconstruction in CT is a mathematical process that generates images from x-ray projection 
data acquired at many different angles around the patient. Image reconstruction has a 
fundamental impact on image quality and therefore on radiation dose. For a given radiation 
dose, it is desirable to reconstruct images with the lowest possible noise without sacrificing 
image accuracy and spatial resolution. Reconstructions that improve image quality can be 
translated into a reduction of radiation dose because images of acceptable quality can be 
reconstructed at a lower dose.
30  
Two major categories of methods of image reconstruction exist, analytical and 
iterative reconstruction. Methods based on filtered-back projection (FBP) are one type of 
analytical reconstruction that is currently widely used on clinical CT scanners because of 
their computational efficiency and numerical stability.
31  
Iteration is defined as a computational process in which a series of operations is 
repeated until a condition is met.
31 
Iterative reconstruction offers the ability to minimize 
radiation exposure while preserving and, in some cases, improving image quality. When CT 
was developed by Godfrey Hounsfield in the 1970’s, the original reconstruction algorithm he 
employed was iterative reconstruction (IR), where the software builds and then revises with 
hundreds of reiterations to enhance image quality. Computer speeds in the 1970’s were so 
slow, it took about 45 minutes to reconstruct one slice using the IR method. The computer 
would work all night to have a rudimentary-quality image ready for viewing the following 
day. A less intense computer power algorithm called filtered-back projection (FBP) was 
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adopted that could process slices in 30 seconds. This software and the incremental 
improvements made to it have been the backbone of CT imaging for more than 30 years.
32  
“You can get a fast answer to the problem of how to take all those inputs into the 
detector and create an image from them. The problem with filtered back projection is that it 
tends to have relatively high noise and relatively high dose,” said Jeffrey B. Mendel, MD, 
staff radiologist, radiation safety officer, Parkland Medical Center, Derry, NH, and assistant 
professor of radiology, Tufts University School of Medicine. Mendel is an expert on CT 
reconstruction software. He said FBP either offers high spatial resolution or high contrast 
resolution, but it cannot do both at the same time. However, IR does offer this ability and can 
do so at a lower dose.
46 
As computing power and speeds rose exponentially in the 1990s and 2000s, IR saw a 
revival, especially in its ability to enhance image quality for lower-dose scans. Lowering CT 
dose became a major issue in recent years after mass media reports of patients receiving 
radiation burns from newer CT scanners. “Here’s the bottom line: radiation is scary and it is 
certainly very scary to the general public,” Mendel said. “The big driver to adopt iterative 
reconstruction is that we can reduce dose.”46 
With IR, the data is processed in a continuous loop where calculations are performed 
to create the different images. Projection data is then processed and compared to assumed 
ideal models over and over to improve the image voxel-by-voxel. 
“Iterative reconstruction solves the equation for each voxel in the image,” Mendel 
said. “It’s a slow, complex calculation, but it offers both low noise and dose, and the ability 
to do both high spatial and contrast resolution together.” 46 
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The technique also creates its own set of image artifacts. Images can appear plastic 
because of the absence of noise, edges are artificially sharper, and the tissue appears to be 
smudged or smoothed. IR can also cause blotchy pattern artifacts inside the borders of 
organs. To reduce the time required to reconstruct IR images and to reduce these artifacts, all 
current IR software programs use a blend of FBP and IR techniques. 
The downside of IR software is that each vendor offers their own version. They can 
be slightly different and have their own strengths and limitations. The software is also 
extraordinarily expensive and would add a significant cost to the imaging machine.
32  
Users of clinical CT scanners usually have very limited control over the inner 
workings of the reconstruction method and are confined principally to adjusting various 
parameters specific to different clinical applications. The reconstruction kernel, also referred 
to as the “filter” or “algorithm” by some CT vendors, is one of the most important parameters 
that affect the image quality. Generally speaking, there is a trade-off between spatial 
resolution and noise for each algorithm. A smooth algorithm generates images with lower 
noise but with reduced spatial resolution. A sharp algorithm generates images with higher 
spatial resolution but increases the image noise.
30 
 
Poor Soft Tissue Contrast 
The characteristic of CBCT that has most limited its use is the poor soft tissue 
contrast. This is due to the intrinsic properties of the acquisition parameters. As previously 
discussed, the pyramidal or cone-beam shape of the x-ray beam results in the development of 
a significant amount of noise, which dramatically decreases the contrast resolution of the 
image. Contrast resolution is the ability of an image to reveal subtle differences in image 
density. Variations in image intensity are a result of differential attenuation of x-rays by 
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tissues that differ in density, atomic number, or thickness. Two principle factors limit the 
contrast resolution of CBCT. First, although scattered photons contribute to increased noise 
of the image, it is also a substantial factor in reducing the contrast of the cone-beam system. 
Scattered x-ray photons reduce subject contrast by adding background signals that are not 
representative of the anatomy, reducing image quality. CBCT units have noticeably less soft 
tissue contrast than MDCT units. 
Second, there are numerous inherent FPD-based artifacts that affect linearity or 
response to x radiation. Saturation (nonlinear pixel effects above a certain exposure), dark 
current (charge that accumulates over time with or without exposure), and bad pixels (pixels 
that do not react to exposure) contribute to nonlinearity. In addition, the sensitivity of 
different regions of the panel to radiation (pixel-to-pixel gain variation) may not be uniform 
over the entire region.
29  
CBCT in Dentistry 
Since CBCT devices were introduced commercially in the United States in 2001, 
dentists have come to use the technology in increasing numbers. Yet, although CBCT 
technologies have advanced rapidly over time, concerns have been expressed about whether 
the information acquired with CBCT imaging warrants the additional exposure risk, as well 
as about the level of training, education, and experience required to interpret the CBCT data 
set.
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To provide guidance on CBCT imaging, national and international groups have 
prepared basic principles, position statements, and professional guidelines for CBCT use. 
These include the American Academy of Oral and Maxillofacial Radiology’s Academy of 
Oral and Maxillofacial Radiology executive opinion statement on performing and 
interpreting diagnostic cone beam computed tomography, 2008; the European Academy of 
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Dental and Maxillofacial Radiology’s Basic principles for use of dental cone beam computed 
tomography: consensus guidelines of the European Academy of Dental and Maxillofacial 
Radiology, 2009; the Academy of Osseointegration’s 2010 Guidelines of the Academy of 
Osseointegration for the provision of dental implants and the associated patient care, 2010; 
The SEDENTEXCT Project’s Radiation Protection: Cone Beam CT for Dental and 
Maxillofacial Radiology: Evidence Based Guidelines 2011; the Joint Position Statement of 
the American Association of Endodontists and the American Academy of Oral and 
Maxillofacial Radiology’s Use of cone-beam computed tomography in endodontics, 2012the 
American Dental Association Council on Scientific Affairs’ advisory statement, The use of 
cone-beam computed tomography in dentistry, 2012; and the Joint Position Statement by the 
American Association of Orthodontists and the American Academy of Oral and 
Maxillofacial Radiologists, Clinical Recommendations for the Appropriate use of Cone Beam 
Computed Tomography (CBCT) in Orthodontics, 2012. 
“In the field of Dentistry CBCT has been researched in the application of the 
following: Three-dimensional measurements and dental implant planning, 
assessment of craniofacial structures for patients undergoing orthognathic 
surgery, three-dimensional imaging in cleft lip and palate patients, diagnostic 
evaluation of osseous abnormalities of the mandibular condyle, detection and 
operative planning for mandibular osteomyelitis, assessment of bone quality, 
surface and volume rendering of facial structures, assessment of 
morphological temporomandibular joint changes, determination of osseous 
lesion size and volume, analysis of the internal structure of tumors, 
preoperative radiographic imaging before lower third molar removal, 
assessment for the reconstruction of the mandibular condyle, detection of 
caries (in vitro study), assessment of external resorption, detection of apical 
periodontitis, detection of foreign bodies in the head and neck region, imaging 
of trauma, and endodontics. It should be noted that restorations adjacent to 
caries lesions will compromise the CBCT detection thereof. For the detection 
of caries intraoral techniques still remain the choice due to their cost benefit, 
accuracy and lower radiation dose. Today, by using the digital data of CBCT 
solid 3D bio-models of human anatomy are fabricated and image guided 
surgery has become a reality. Due to advantages such as low radiation doses, 
convenience, simplicity, saving of time during procedures as well as lower 
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initial and long-term costs of CBCT over conventional CT it is believed by the 
authors that the demand for CBCT will increase in the field of maxillofacial 
imaging.” 34 
The authors of the above referenced statement did not specifically mention CBCT in 
orthodontics. However, the field of orthodontics has seen tremendous growth in the use of 
CBCT for obtaining pre-treatment records, establishment of treatment plans, and mid-
treatment evaluation.
35 
In addition, CBCT is used in orthodontics for determination of 
appropriate sites for mini-screws, palatal bone thickness, cephalometry, assessment of tooth 
position or inclination, assessment of rapid palatal expansion, determination of skeletal age 
based on cervical vertebrae morphology, and 3D evaluation of upper airway anatomy in 
adolescents.
36 
The use of CBCT in dentistry, and particularly orthodontics, is not without 
controversy, mainly because the majority of the patient population undergoing orthodontic 
treatment is in the pediatric to adolescent age group. It is well known that children have a 
significantly elevated risk of untoward side effects, namely a lifetime risk of cancer, when 
exposed to radiation.
37  
There are two types of effects on tissue caused by radiation. If cellular damage occurs 
as a result of radiation and it is not adequately repaired, it may prevent the cell from 
surviving or reproducing or it may result in a viable cell that has been modified (suffered a 
change or mutation). The two scenarios have profoundly different outcomes for the patient.  
Deterministic effects occur when there is significant damage to the cell or tissue resulting in 
loss of function. Above a certain dose, the threshold dose, the probability of manifestation 
increases swiftly to 100%. The severity and occurrence increase with dose (e.g., cataract, 
tissue fibrosis). The probability of such harm is zero at small radiation doses observed in 
medical imaging. 
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The consequence is very different if the irradiated cell remains viable but has been 
altered. Carcinogenesis and heritable effects fall into this category. When somatic cells are 
exposed to radiation, the probability of cancer rises with dose, most likely with no threshold, 
as in the deterministic response. However, the severity of the cancer is not dose related. This 
category is referred to as stochastic effects. If the radiation occurs to a germ cell, mutations 
could result that could have harmful effects in future generations. It is also believed that there 
is probably no threshold and the severity of heritable effects is not dose-related, just hat the 
probability increases with dose.
38 
The belief that stochastic effects have no dose threshold is 
based on the molecular mechanisms involved. There is reason to believe that even a single x-
ray photon could result in a base change, leading to a mutation that could cause cancer or a 
heritable defect. This concept is also referred to as the Linear No-Threshold (LNT) risk 
assessment model that any amount of radiation exposure may lead to cancer in a population. 
Based on the LNT model, risk from low-dose radiation increases linearly with increasing 
doses of radiation. It is thought that extrapolating the linear graph into the very-low-dose 
range is also accurate. For this reason, it is considered sensible and conservative to assume 
that no dose is too small to be effective, although this can never be proved.
38 
 
Cancer induction is the most important somatic effect of low-dose ionizing radiation. 
There is a long history of a link between radiation exposure and an elevated incidence of 
cancer. Many reports have been made but the most recent and significant example of human 
experience with radiation-induced cancer includes the Japanese survivors of the atomic bomb 
attacks. This is the most important single group studied because of their large number, the 
care with which they have been followed, and the fact that people of all ages and both sexes 
received a wide range of doses.
39 
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Irradiation of Children 
The hazards associated with medical radiation in children are basically the same as in 
adults, cancer and heritable effects. However, the risks associated with a given absorbed dose 
of radiation are higher because of an increased sensitivity in younger people. This was 
evident in the survivors of the of the Japanese atomic bomb attack (Life Span Study, LSS, 
Radiation Effects Research Foundation, RERF). There is a noticeable alteration in sensitivity 
to radiation-induced malignancies with increasing age, with young children being more 
radiosensitive than older adults by a factor of 10-15. Concern for possible heritable effects 
induced by radiation is similarly greater in children because they have their entire 
reproductive life ahead of them.
38 
 
With radiation-induced cancer, there is a latent period between irradiation and the 
appearance of the malignancy. There is also a difference in the type of cancer that develops. 
Leukemia has the shortest latent period. Excess cases began to appear in the survivors of the 
Japanese atomic bomb attack and reached a peak in 5-7 years and extended to about 15 years. 
Solid tumors, on the other hand, show a longer latency and extend from 10 to about 60 years 
out from the time of irradiation.
38 
 
The Position Statement by the American Academy of Oral and Maxillofacial 
Radiologists, 2012, outlined a series of  
“general recommendations and specific criteria for the use of CBCT based on 
specific clinical scenarios and most appropriate scan field of view.”… “Dose 
minimization and professional use strategies are provided. The use of CBCT 
must be justified based on individual clinical presentation and is not 
appropriate for routine diagnostic use nor as a substitute for non-ionizing 
radiation techniques to record the dentition or maxillofacial complex.”40  
The issue of dose was also addressed in the Position Statement. “The recent results of 
a retrospective cohort study by Pearce, et al. 2012, provided more direct evidence of a link 
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between exposure to radiation from computed tomography (CT) and cancer risk in 
children.”40  They found that “children and young adults who received radiation doses from 
the equivalent of 2 or 3 CT scans of the head have almost triple the risk of developing 
leukemia or brain cancer later in life. Medical CT scans may have an effective dose of up to 
2000 µSv,”41 “However, substantial reductions to less than 1,000 µSv have been reported for 
low dose protocol CT examinations.”12, 42 “Most CBCT examinations are reported to impart a 
fraction of medical CT effective dose, however, doses vary considerably between CBCT 
units.”40  
“The actual risk of cancer induction for low dose radiographic procedures currently 
considered to be below about 100,000 μSv, including as maxillofacial CBCT, is difficult to 
assess. Radiation epidemiologists and radiobiologists internationally are in consensus that for 
stochastic risks such as carcinogenesis, from a radiation safety perspective, the risk should be 
considered to be linearly related to dose, all the way down to the lowest doses.”43  
In this paper, the AAOMR Task Force Committee reviewed information on the 
potential health effects of exposure to diagnostic ionizing radiation. There is neither 
convincing evidence for carcinogenesis at the level of dental exposures nor the absence of 
such damage. This situation is unlikely to change in the foreseeable future. In the absence of 
evidence of a threshold dose, it is prudent to assume that such a risk exists. This implies that 
there is no safe limit, or safety zone, for ionizing radiation exposure in diagnostic imaging. 
Every exposure cumulatively increases the risk of cancer induction. Consequently, to be 
cautious, the Committee’s recommendations are focused on minimizing or eliminating 
unnecessary radiation exposure in diagnostic imaging.
40 
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The release of the Position Statement by the AOAOMR was followed quickly by 
responses that were not in agreement with the recommendations in the document. Mah, et al. 
responded with an article in Orthodontic News that was highly critical and stated,  
“The AAO/AAOMR draft document is lacking in many respects related to 
objectivity, balance, failure to apply the available evidence, and flawed 
recommendations. As is, it may be impossible for AAO members to follow 
the guidelines and may put them, their practices, and the AAO in difficult, if 
not impossible, situations.”44  
The use of CBCT in dentistry shows no sign of decelerating. More and more uses will 
be found. Manufacturers of CBCT machines will continue to respond to the increasing 
demand by offering units that will satisfy the needs of practitioners and their patients. 
Computers, detectors, monitors, and software algorithms will all continue undergo 
technological advancements. It is an important public health issue that ALARA will continue 
to be respected and the dose received by patients reduced while the benefits of the 
technology realized. 
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CHAPTER 2. ASSESSMENT OF PHANTOM DOSIMETRY AND IMAGE QUALITY 
OF ACCUITOMO 170 AND MINICAT CONE-BEAM COMPUTED TOMOGRAPHY 
Introduction 
Imaging with x-rays has been an integral adjunct to the history and physical 
examination to assist the clinician with determining an accurate diagnosis. For over a 
century, technological innovation has propelled radiographic imaging to the forefront of 
progressions in health care. Computed tomography (CT) technology advanced to a point in 
the 1990’s that allowed very detailed, high-quality images of internal anatomy to be acquired 
in a matter of seconds. Use of CT skyrocketed and it became routine for doctors to order a 
CT scan as part of their patient evaluation practice. When the total number of CT imaging 
scans obtained during the period from 1993 to 2006 are tabulated, an exponential rise in the 
number of examinations far exceeds the growth in the U.S. population over the same period.
1 
In 1990 and 2000, approximately 13 million and 46 million CT scans were performed, 
respectively.
2   
Most reports put the number of CT scans performed annually in the United 
States to be between 70 million and 80 million.
2 
(Figure 1) 
A study in the journal Radiology revealed that the number of CT scans performed on 
pediatric patients in the emergency department (ED) had increased fivefold over a 13-year 
period ending in 2008.
3 
This pattern essentially duplicates what has happened with CT scans 
for adult patients in the ED. “The main driver is, frankly, that CT is an amazing technology,” 
said Marilyn Goske, MD, a pediatric radiologist at Cincinnati Children’s Hospital Medical 
Center. “Thirty years ago, we couldn’t see inside the brain. Now, we can do a child’s body in 
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half a second. We have technology that gives us exquisite imaging and we don’t need to 
sedate the child. We can have a definitive answer.”“ … That level of accuracy has improved 
the quality of pediatric care, making procedures such as exploratory surgery for tumors and 
staging laparotomies for lymphoma no longer necessary.”4 Donald Frush, MD, a pediatric 
radiologist at Duke University Health System, echoes this point. Twenty years ago, he noted, 
the accepted false-negative rate for laparotomies for appendicitis was 30%; with the 
availability of CT, the false-negative rate has dropped to the 5–7% range.4  
In general, the benefits of radiation for diagnostic purposes far outweigh the risks 
regarding the health of patients.
5
 However, there has been a growing concern that perhaps too 
much imaging is occurring and it may be detrimental to public health. The most severe long-
term side effect of exposure to x-rays are stochastic effects, or cancer. Even low levels of 
radiation received from imaging diagnostic procedures, such as CT, do have the potential to 
cause stochastic effects, which basically refers to the development of various malignancies 
due to genetic mutations.
6,7,8
 Stochastic effects are considered to have no radiation threshold, 
meaning that even a very small dose has the potential to cause cancer. A review paper 
published at the end of 2007 in the New England Journal of Medicine (NEJM), estimated that 
from 1.5% to 2% of all cancers in the United States may be attributable to the radiation from 
computed tomography (CT) studies.
30
 This study, as well as others,
10, 11 
have generated a 
slightly raucous public health concern that has even reached high-profile media regarding the 
use of CT scans in medicine and now the use of cone-beam computed tomography (CBCT) 
in dentistry.  
A well-publicized article in The New York Times in 2010 discussed the use of CBCT 
scans in adolescents and the potential risks of radiation induced carcinogenesis.
12 
CBCT 
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examinations have been reported to deliver a fraction of the dose of a head CT exam, which 
is approximately 2 mSv (2000 µSv).
13 
However, CBCT scanners have been notorious for 
producing large variations in dosage based on the manufacturer, field of view (FOV), 
exposure factors, and other options present on the machine. This variability of exposure can 
be as much as ten-fold.
14,15 
The range of differences is especially important when considering 
the pediatric patient population because cellular growth and organ development is associated 
with an increased radiosensitivity. When coupled with a probability of a longer lifespan in 
which stochastic effects may occur, children may be two or more times as sensitive to 
radiation-induced carcinogenesis as mature adults.
16 
 
Exposure to Radiation 
On earth we are exposed to two major sources of radiation: background and medical. 
The background radiation is basically fixed and beyond our control, with a consistent annual 
dose being delivered. The single highest controllable source of radiation exposure in the U.S. 
population is from medical imaging, with the majority associated with diagnostic procedures. 
In 2006, the medical use of radiation, not including radiation therapy, produced an average 
annual effective dose to the population of the United States of roughly 3 mSv. This equates 
to about 97% of the total from artificial radiation sources and nearly half of the average 
annual effective dose from all sources, including background radiation (NCRP, 2009). 
(Figure 2) When CT scanning was in its infancy in 1980, the estimated average annual 
effective dose equivalent from medical radiation was 0.3 mSv (NCRP, 1987). The two 
largest factors that increased the average effective dose from 1980 until 2006 are the 
increased use of computed tomography (CT) and nuclear medicine, with CT exposure 
accounting for greater than 2/3’s of the total. These two combined deliver approximately 
40 
75% of the collective medical effective dose. The average U.S. per capita dose in 1980 was 
0.53 mSv and rose to 3.0 mSv in 2006, an increase of 566% (NCRP, 1987; NCRP, 2009)
1
. At 
this point the total average annual effective dose per person in the U.S. population is 6.2 
mSv—background, 3.1 mSv/yr, and medical, 3.0 mSv/yr. (The .1 mSv discrepancy is 
attributed to consumer products and other, (NCRP, 2006).)
17
 It is easy to extrapolate that if 
exposure to ionizing radiation continues at this rate of growth, the overall public health will 
be negatively impacted. 
Measuring Dose 
The most pertinent manner to measure dose in humans is related to the ability of 
ionizing radiation to induce formation of malignancy in the tissue of the exposed individual. 
Equivalent dose is used in radiological protection to represent the stochastic (probability of 
cancer induction and genetic effects) but not deterministic effects (severity of acute tissue 
effects) of ionizing radiation. The equivalent dose is calculated by multiplying the absorbed 
dose by a radiation weighting factor appropriate to the type and energy of radiation. 
Equivalent dose, HT, is used for assessing stochastic health risk due to external radiation 
fields that penetrate uniformly through the whole body, or for assessing the individual 
equivalent dose to organs. However, it needs further corrections when the field is applied 
only to part(s) of the body or non-uniformly to measure the overall risk. In that case, a further 
quantity called effective dose must be used to take into account the varying sensitivity of 
different organs and tissues to radiation. The radiation dose quantity effective dose is the 
tissue-weighted sum of the equivalent doses in all specified tissues and organs of the body 
and represents the stochastic health risk, which is the probability of cancer induction and 
genetic effects of ionizing radiation delivered to those body parts.
6
 It takes into account the 
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type of radiation and the nature of each organ or tissue being irradiated. Effective dose is the 
central quantity for dose limitation in radiological protection in the international system of 
radiological protection devised by the International Commission on Radiological Protection 
(ICRP) 103.
6 
The calculation of effective dose is required for partial or non-uniform irradiation of 
the human body because equivalent dose does not consider the tissue irradiated, only the 
radiation type. However, various body tissues react to ionizing radiation differently. The 
ICRP has assigned sensitivity factors to specified tissues and organs so that the effect of 
partial irradiation can be calculated if the irradiated regions are known.
6
 A radiation field 
irradiating only a portion of the body will carry lower risk than if the same field irradiated the 
whole body. To take this into account, the effective doses to the component parts of the body 
that have been irradiated are calculated and summed. This becomes the effective dose for the 
whole body, dose quantity E. It is a “protection” dose quantity that can be calculated but 
cannot be measured in practice. Therefore, different probabilities exist for the occurrence of 
stochastic radiation effects in various organs and tissues.  
There are multiple means to measure the dose delivered to a patient: computed 
tomography dose index by volume (CTDIvol), dose area product (DAP), entrance surface 
dose (ESD), air kerma—area product and Monte Carlo simulations.2 The method chosen by 
the International Commission on Radiation Protection (ICRP) is effective dose, which is the 
most widely accepted. As stated previously, E is a weighted average of organ doses and can 
be expressed mathematically as follows: E = Σ WT x HT, where E is the summation of the 
products of the tissue weighting factor (WT ) that represents the relative contribution of that 
organ or tissue to the overall risk and the radiation weighted dose (HT ).
28 
The effective dose 
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is expressed in Sieverts (Sv, mSv, or µSv). The dissimilar sensitivity to stochastic radiation 
damage was considered in the ICRP Publication 60 by the tissue-weighting factor in 
calculations of the effective dose. Tissue weighting factors (WT) were established by the 
ICRP as part of a radiation protection system to assign a particular organ or tissue (T) the 
proportion of detriment from stochastic effects (ICRP Publication 60, 1990, and updated 
Publication 103, 2007.)
18 
Using extrapolations of cancer morbidity and mortality data 
associated with well-documented exposures to large populations such as the survivors of the 
atomic bomb explosions, radiation detriment, including the weighted probabilities of fatal 
and non-fatal cancer, can be calculated from effective dose.
1 
Importantly, effective dose is an 
indicator for stochastic risk but because of the uncertainties in the low-dose range, underlying 
approximations, simplifications, sex and age averaging, it applies to a population, not to a 
specific individual. Therefore, effective dose should not be used as the patient’s dose for the 
purpose of assigning risk.
17  
For a number of reasons the ICRP has produced recommendations three times in the 
past 35 years—1977, 1990, and 2007 (Table 1). Tissue-weighting factors were first updated 
13 years after basic recommendations were made in 1977 Publication 26. In the 1977 
recommendations, the ICRP introduced the distinction between “stochastic” effects and 
“non-stochastic” effects of radiation exposure. Although it gave no risk figures for non-
stochastic effects, it gave quantitative estimates of the stochastic risk of radiation exposure 
for the first time. The Commission derived cancer risk factors for red bone marrow, bone, 
bone surfaces, lung, thyroid, breast, and “all other tissues.” It was recognized that the risk 
estimates would vary between workers in the field and the general population.
37 
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In the 1990 ICRP recommendations, there was a review of non-stochastic, now 
renamed “deterministic,” effects in organs and tissues and estimates were given for the 
thresholds of these effects. There was also a rigorous review of the stochastic effects in 
exposed individuals. There was a longer list than in 1977 of organs and tissues for which 
risks were quantified, some 13 organs plus gonads. The Commission increased the 
probability coefficients for stochastic effects leading to a fatal cancer risk from 10
-2 
Sv 
-1 
in 
1977 to 5.0 10
-2 
Sv
-1
. The estimates represented a significant increase over those from 1977 
and caused some major changes to protection philosophy. The principal reason was due to 
the “multiplicative model” replacing the previous “additive model” (radiation risks assumed 
to be induced “independent” of the naturally occurring cancers) used in 1977. By the late 
1980’s, there were more solid tumors recorded in the Japanese Atomic Bomb survivor’s, 
indicating there is a longer “latent period” for solid tumors compared to leukemia. The 
increased numbers lead to the conclusion that the radiation-induced tumors were consistent 
with the “multiplicative model,” whereby the tumors induced by radiation arise as a 
percentage increase of those naturally arising. This led to an increased estimate of the tumors 
that would develop in the future because natural cancer rates generally increase with higher 
ages.
37
 
In 2007, the International Commission on Radiological Protection (ICRP) updated the 
method for calculating effective dose on the basis of the latest available scientific 
information on the biology and physics of radiation exposure.
28 
The new method involves 
revised estimates of the radiosensitivity of tissues and their corresponding tissue-weighting 
factors, including those in the maxillofacial region. The 2007 ICRP tissue and tissue-
weighting factors reflect new data updated through 1998 from the Life Span Study of 
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Japanese atomic bomb survivors. This data provided information regarding cancer incidence 
and not just cancer mortality, which is a more accurate description of the cancer burden from 
exposure to radiation because some cancers now have a relatively higher survival rate.
38
 Of 
particular relevance to dentistry, salivary glands, oral mucosa, and extrathoracic airway 
tissues were included in the weighting system and brain tissue weighting was increased. An 
increasing evidence of cancer risk in salivary glands and brain, linked to dental 
radiography,
39
 caused these tissues to be given increased weight in 2007. The revision of the 
tissue-weighting factors, despite reducing the weighting of the thyroid gland from 0.05 to 
0.04, has resulted in an increase in the calculated effective dose to the tissues in the 
maxillofacial region and concomitantly increased the risk of the detrimental outcome of the 
stochastic effect of cancer.
38 
Ludlow et al. demonstrated in a 2008 article in JADA that the 
application of the 2007 ICRP guidelines to common dental imaging examinations resulted in 
a 32-422% higher risk of detrimental effects to the patient than from the 1990 ICRP 
guidelines.
38
  
Image Quality 
The aim in radiology is to obtain images that are adequate for the clinical purpose 
with the minimum radiation dose to the patient. Superior image quality is certainly available 
with the CBCT machine, but it comes at a high cost to the patient in the form of significant 
doses that are nearly equivalent to MDCT.
15
  If optimum performance is to be achieved, 
assessments of image quality must be made to balance against patient dose. The subjective 
nature of image interpretation makes an objective approach to such assessment difficult. 
There are two components of subjective image quality that relate with objective quality 
measures: contrast and spatial resolution. Image contrast can be objectively measured using 
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contrast-to-noise ratio (CNR) and spatial resolution is tabulated by computing a modulation 
transfer function (MTF).  
As the technology and use of CBCT continues to evolve, there is a shift away from 
the “one size fits all” mentality of imaging. The newer units are being designed in a manner 
that answers to both the needs of the practitioner and the principles of ALARA. Many 
contemporary, innovative CBCT units have a plethora of options for FOV, projection 
images, exposure factors, and modes that enable the savvy practitioner to precisely obtain the 
diagnostic image required without undue exposure to the patient. For example, if the patient 
needs only one or two implants adjacent to each other in the arch, then a very small FOV 
with high resolution can be chosen to capture only the anatomy of interest, thereby avoiding 
irradiating an outsized volume of tissue with a large FOV. Conversely, when evaluating the 
general position of tooth roots midway through orthodontic treatment, a large FOV may be 
chosen with a concomitant reduction in the technical factors to decrease the ultimate dose 
received by the patient because a high resolution is not required to obtain the desired 
information. 
The purpose of this research study was to determine equivalent doses and calculate 
effective doses based on various combinations of FOV size, location, and exposure protocols 
using adult and child ATOM® and (optically stimulated luminescent dosimeters (OSL’s) 
with the MiniCAT (Xoran Technologies, Ann Arbor, MI) and Accuitomo 170 (J. Morita 
Corporation, Osaka, Japan) CBCT units. The second objective was to measure contrast-to-
noise ratio and modulation transfer function as quantitative measurements of image quality 
for various exposure options offered by the Accuitomo 170 machine.
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Materials and Methods
 
Optically stimulated luminescent (OSL) dosimeters (Nanodot; Landauer, Glenwood, 
IL) were used in this project to measure absorbed dose. OSL’s were demonstrated by Ludlow 
et al.
26
 to be an accurate and easier-to- process alternative than the previous 
thermoluminescent dosimeters (TLD), customarily used in prior dosimetry studies. OSL 
dosimeters are plastic disks, each encased in a light-tight plastic holder measuring 
approximately 2 x 10 x 10 mm (Figure 3A). The case prevents loss of energy through 
stimulation by ambient light. Each disk is infused with aluminum oxide doped with carbon 
(Al2O3:C). The trace amounts of carbon in the aluminum oxide crystal lattice create 
imperfections that act as traps (F centers) for electrons and positively charged areas called 
“holes.” After exposure to ionizing radiation, free electrons and holes are generated and 
trapped at the F centers in proportion to the amount of energy in the exposure.
26
 Release of 
trapped electrons and light emission are stimulated by laser light instead of heat, as in TLD’s. 
OSL dosimeters have a broad dose response range and are capable of detecting doses as low 
as 10 µSv. The Al2O3 has a higher effective atomic number than soft tissue. Consequently, an 
OSL dosimeter has filters over the sheet of OSL material that are used to estimate dose to 
soft tissue. OSL’s have certain advantages over TLD’s in that they can be reread several 
times and an image of the filter pattern can be produced to differentiate between static (i.e., 
instantaneous) and dynamic (i.e., normal) exposure.
17
  
Dosimeters used in this study were calibrated before use and read with a portable 
reader (MicroStar; Landauer, IL) (Figure 3B). After calibration, photon counts from 
dosimeters can be recorded with an accuracy of about + or -2%.
26
 Photon counts are 
converted to doses using an energy-specific conversion factor. In this case, doses reported by 
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the reader were adjusted for energy response. 
 
Doses reported by the MicroStar reader were 
adjusted for dosimeters over a range of 80 to 120 kVp using an adjustable kilovolt peak 
source.
26 
For this study, the OSL sensitivity, at 90 kVp, was the estimated energy response 
using a third-order polynomial calibration curve derived from side-by-side comparisons of 
recorded doses from an ion chamber and OSL at .94 (mean, 60 kV). OSL sensitivity at 120 
kVp was estimated at 0.78 (mean, 80 kV). 
Two different models of CBCT machines were used for this investigation. The 
MiniCAT (Xoran Technologies, Ann Arbor, MI) (Figure 4) and the Accuitomo 170 unit (J. 
Morita Corporation, Osaka, Japan). The MiniCAT unit is more simplistic from the standpoint 
of offering fewer options, such as FOV, selection of mode, and adjustable exposure factors. It 
offers two fields of view (16 x 13 cm sinus and a 16 x 6.5 cm temporal bone) (Figure 5) and 
operates at a tube voltage of 120 kVp and 125 kVp, respectively, for the sinus and temporal 
(T-bone) scans. The tube current remained at 7 mA for all the scans. The pulse length is 11.5 
ms for the three sinus scan options and a pre-set 14 ms for the T-bone. Additionally, the 
MiniCAT permits three options for projection image selection (600, 300, and 150) with 
exposures of 48.30 mAs/20 s, 24.15 mAs/10s and 12.08 mAs/10s for the sinus scans. The T-
bone scan has only one set of parameters, which includes 600 projection images, 58.80 mAs, 
and a scan time of 20 s. The scan parameters pre-set by the manufacturer for the adult and 
child phantom using the MiniCAT are listed in Figure 7.  
The Accuitomo 170 is a more contemporary unit with multiple options and the ability 
to tailor the scan to meet more specific criteria (Figure 8). The machine offers nine fields of 
view (FOV), which ranged from 40 x 40 mm to 170 x 120 mm. The unit operates at 60 to 90 
kV, 1 to 10 mA, with a pulsed exposure and four voxel sizes (80, 125, 160, and 250 µm), and 
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offers four modes with associated time in seconds (Standard: 17.5/9.0 sec., Hi-Fidelity: 
30.8/15.8 sec., Hi-Resolution: 30.8/15.8 sec., Hi-Speed: 10.5/5.4 sec.) and two rotation 
options (360°/180°). The scan parameters for the Accuitomo 170 used for the adult and 
pediatric phantoms are given in Figure 9.  
Adult dosimetry was acquired using a tissue-equivalent phantom simulating the 
anatomy of an average adult male (ATOM Max model 711 HN; CIRS, Norfolk, VA) as was 
used in the research conducted by Ludlow et al., 2013.
26
 The phantom material includes 
detailed 3D anthropomorphic anatomy including brain, bone, larynx, trachea, sinus, nasal 
cavities, and teeth. The bones contain both cortical and trabecular separations. The phantom 
was modified by machining slots to accept Nanodot OSL dosimeters at sites corresponding to 
the internal tissues of interest (Figure 10). A skin surface dosimeter in the back of the neck 
was positioned at the vertical center of the designated slice level and taped in position. Lens 
of eye dosimeters were centered over and inset in the anatomic location for the lens and taped 
in position. Internal dosimeters were positioned vertically with the upper edge of the 
dosimeter slot flush with the surface of the selected slice level and held in position by friction 
of the dosimeter case and the phantom material at the sampled anatomic location. Adult 
dosimeter anatomic locations and phantom levels are shown in Figure 11. During scanning, 
the phantom was oriented with its section planes approximately parallel to the scan rotation 
plane (horizontal). A phantom position was chosen that simulated the positioning of a patient 
on the chin rest. With the exception of the 16 x 6.5-cm T-bone FOVs in the MiniCAT and the 
smaller FOV’s in the Accuitomo that did not capture the chin or maxillary incisal teeth, 
centered FOVs were positioned to capture approximately 5 mm of soft tissue below the lower 
cortical border of the chin and approximately 5 mm below the maxillary central incisor edge 
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and the tip of the nose to offer consistency in the location and anatomy in the chosen FOV. 
The anteroposterior position of the phantom was established to capture approximately 5 mm 
of soft tissue anterior to the facial surface of the maxillary incisor crowns.  
Child dosimetry was acquired using a tissue-equivalent phantom simulating the 
anatomy of a 10-year-old child (ATOM model 706 HN; CIRS). Tissues simulated in this 
phantom were average soft tissue, average bone tissue, spinal cord, spinal discs, brain, and 
sinus. Simulated bone tissue matches age-related density. The child ATOM phantom, 
dosimeter anatomic locations, and child phantom levels are shown in Figure 12 A, B. With 
the exception of the 16 x 6.5-cm T-bone FOV, centered maxillofacial FOVs were positioned 
to capture approximately 5mm of soft tissue below the lower cortical border of the chin. The 
anteroposterior position of the phantom was established to capture approximately 5mm of 
soft tissue anterior to the facial surface of the maxillary incisor crown. For the 16 x 13-cm 
sinus views, the lower border of the FOV was positioned approximately 5 mm below the 
maxillary central incisor edge. For the 16 x 13-cm maxillofacial views, the tip of the nose 
and the lower soft tissue border of the chin were included in the FOV. Example volumes 
produced by the ATOM child phantom for the Xoran MiniCAT are shown in Figure 13. 
Representative volumes for the appropriate FOV’s for the adult and child ATOM phantoms 
using the Accuitomo 170 unit are shown in Figure 14. 
One to ten exposures were used for each dosimeter run to provide a more reliable 
measure of radiation captured in the dosimeters. Smaller FOVs required more exposure 
repetitions because more dosimeters are outside the field of direct exposure and absorb only 
small quantities of scatter radiation. For every scan, a scout view was also acquired. Doses 
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recorded by the OSL dosimetry reader were divided by the number of scans to determine the 
exposure per examination for each dosimeter. 
Doses recorded by OSL dosimeters at different positions in a tissue or an organ were 
averaged to express the average tissue-absorbed dose in micro-grays. The products of these 
values and the percentage of a tissue or an organ irradiated in a radiographic examination 
were used to calculate the equivalent dose in micro-Sieverts (µSv). 
For bone, the equivalent dose to the whole-body bone surface was calculated using 
the summation of the individual equivalent doses to the calvarium, mandible, and cervical 
spine.
26
 The determination of these equivalent doses was based on the distribution of bone 
throughout the body: the mandible contains 1.3%, the calvaria 11.8%, and the cervical spine 
3.4%.
8   
Distribution of adult bone marrow was calculated using an average of data from 
Christy
9
 for 25- and 40-year-olds. The mandible contains 0.8%, the calvaria 7.7%, and the 
cervical spine 3.8% of the adult marrow distribution. The 10-year-old child’s marrow 
distribution was calculated as 1.1% for the mandible, 11.6% for the cranium, and 2.7% for 
the cervical spine, for a total of 15.4% of the total body marrow with the technique of 
Underhill et al.
8 
(Table 2). Three locations in the calvarium were averaged to determine the 
calvarial dose. For bone, a correction factor based on experimentally determined mass energy 
attenuation coefficients for bone and muscle irradiated with mono-energetic photons was 
applied. An effective beam energy estimated to be 2/3rds of the peak beam energy of the x-
ray unit was used to determine the bone-to-muscle attenuation ratios.
26
 A linear fit (R
2 
= 
0.996) of ratios from 40 to 80 kV from published data produced the following equation: 
bone-to muscle attenuation ratio equals 0.0618 x kVp x 2/3 + 6.9406.
45
 Values calculated 
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from this equation provided bone-to-muscle attenuation ratios of 3.21 at 60 kV (90 kV[p]) 
and 1.97 at 80 kV (120 kV[p]).
26 
The proportion of skin surface area in the head and neck region directly exposed 
during maxillofacial CBCT imaging is estimated at 5% of the total body to calculate the 
radiation-weighted dose to the skin following the procedure per Ludlow et al.
27 
Likewise, 
muscle and lymphatic node exposures are estimated to represent 5% of the total body 
complement for these tissues. The proportion of the esophageal tract that is exposed was set 
at 10%. Other tissues of interest were calculated at 100%.
26 
See Table 2 for the list of tissue 
percentages irradiated in the adult and child phantoms and the location of each dosimeter in 
the phantom. 
Effective Dose 
X-ray imaging involves only partial-body exposure. As stated previously, when only 
part of the body is exposed, the risk of a stochastic radiation response is not proportional to 
the tissue dose but rather to the effective dose (E). E is a weighted average of organ doses 
and can be expressed mathematically as follows: E = Σ WT x HT, where E is the summation 
of the products of the tissue weighting factor (WT ) (Table 1), which represents the relative 
contribution of that organ or tissue to the overall risk, and the radiation weighted dose (HT ).
28 
To put this into perspective, Huda (2006) emphasizes that “the total amount of radiation that 
a patient receives in any radiographic examination is best quantified by the effective dose, 
which is related to the risk of carcinogenesis, and with the induction of genetic effects.”29  
The whole-body risk is determined by the summation of the radiation-weighted doses 
to all tissues or organs exposed. International Commission on Radiological Protection (ICRP) 
weighting factors in Table 1 were used to calculate the effective doses.
28 
Tissue weighting 
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factors used in ICRP calculation of effective dose include 14 independently weighted tissues 
and 14 remainder tissues.
28   
Because the uterus and the cervix are present only in females and 
the prostate only in males, the number used in the weighted averaging of the remainder 
tissues was 13.
26
 
Statistics 
Analysis of variance (ANOVA) of effective dose results was used to evaluate the data 
for significant differences caused by the adult versus the child ATOM phantom, FOV, 
location, and unit mode. When significant differences were found, the Tukey HSD test was 
used to determine which factors were significantly different from other factors. An alpha 
value of 0.05 was selected for all tests.  
 The image quality indicators, modulation-transfer-function (MTF) and contrast-to-
noise-ratio (CNR), were also evaluated as part of the research project. Spatial resolution is 
the ability of an imaging system to resolve and render on the image a small high-contrast 
object. Spatial frequency is expressed in line pair per millimeter (lp/mm).
32
 Anatomy can be 
described as having spatial frequency. For example, large soft tissues such as the liver, 
kidney, and brain have a low spatial frequency and are easy to image. Bone trabeculae, breast 
microcalcifications, and contrast-filled vessels are high-frequency objects and are more 
difficult to image. An imaging system with higher spatial frequency has better spatial 
resolution. Spatial resolution in all of the digital imaging modalities is limited by the size of 
the pixel. No digital imaging system can image an object smaller than one pixel.
32 
MTF has 
been applied to the description of the ability of an imaging system to render objects of 
different sizes onto an image. Objects with high spatial frequency are more difficult to image 
than then those with low spatial frequency. This is similar to saying that small objects are 
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more difficult to image than large objects. Regardless of the size of the object, the object is 
considered to be high contrast for the purpose of MTF evaluation. MTF can be viewed as the 
ratio of image to object as a function of spatial frequency. An ideal imaging system is one 
that produces an image that appears exactly as the object. Such a system would have an MTF 
equal to one and the ideal imaging system does not exist. It is said that the human eye can 
only differentiate about 10% of MTF.
32  
When an imaging system is evaluated through the 
MTF method, the 10% MTF often is identified as the system spatial resolution
32 
 
 Using a QUART DVT AP phantom and QUART DVT TEC software (QUART, 
Zorneding, Germany) (Figure 14). Volumes were acquired with the different technical 
factors evaluated in the dosimeter portion of this study. The phantom consisted of 16-cm-
diameter cylindrical slabs of acrylic plastic with polyvinyl chloride and air elements 
configured to permit measurements on axial images selected from the volume. Measurements 
included polymethylmethacrylate voxel, polymethylmethacrylate noise, homogeneity, 
contrast, contrast-to-noise ratio, modulation transfer function 10%, modulation transfer 
function 50%, and Nyquist frequency. The measurements were calculated in a user-guided, 
semiautomatic manner from two DICOM slices selected from the volume. Each volume was 
measured 3 times, and averages and standard deviations of each parameter were calculated.
26  
Results 
Due to the substantial differences with regards to selecting options for field-of-view, 
exposure factors, and protocol between the MiniCAT and Accuitomo 170 machines, the data 
from the two units was evaluated separately. Beginning with the MiniCAT unit, Tables 3 and 
4 highlight the effective dose calculations, protocol parameters, and the percentage increase 
for the ATOM adult and child phantoms. The 16 x 13 cm sinus and maxillofacial scans 
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differed only by selecting 150, 300, or 600 frames and the location of the chosen FOV. The 
MiniCAT machine also has a field-of–view option specifically to evaluate the temporal bone 
(16 x 6.5 cm with pre-set exposure factors). The exposure factors of kVp, mAs, and pulse 
remained unchanged when the number of frames were selected. Table 4 shows the protocols 
were identical and the increased doses ranged from 44-89%, with the child phantom effective 
doses, on average, 60% greater than adult phantom doses. Figure 16 is a graphic 
representation of the data in Table 3. Additionally, the effective doses were also calculated 
specifically for the thyroid gland in both the adult and child phantoms. The effective doses 
varied between 5.8 and 45.3 µSv for the adult and between 11.0 and 100.0 µSv for the child, 
Table 5 and Figure 16, respectively. The increase in the thyroid effective doses for the child 
ranged between 61 and 120% (mean 92%) and are shown in Table 6 and Figure 18. When the 
child sized exposure parameters were used (3 mA) the effective dose was approximately 
equal to the adult effective dose. 
The Accuitomo 170 is a more complex machine with nine FOVs and multiple options 
to select for exposure factors and protocol. Table 7 demonstrates the calculated effective dose 
for both the adult and child phantom beginning with the smallest FOV and ending with the 
largest FOV (6 x 6 cm to 17 x 12 cm). For smaller FOV groups, data was acquired by 
modifying the protocol and location of the particular FOV. As depicted in the graph in Figure 
19 these modifications can have a considerable impact on the value of the effective dose 
calculated for the scan. FOV is shown to have the principal influence on the eventual 
effective dose. However, the specific location of the FOV, as well as the imaging mode (360° 
vs. 180° scan, basis projections, time, and pixel size) will make contributions to the ultimate 
effective dose received by the phantom. Table 8 and Figure 20 demonstrate the effective dose 
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to the thyroid gland in both the adult and child phantom. Again, there is a definite 
relationship of an increasing dose associated with increasing the FOV, which in turn is 
modified by the changes to the imaging mode. Table 9 and Figure 21 show the dose to the 
thyroid gland generates a sizeable portion to the percentage increase of the final effective 
dose received by the child phantom based on the FOV and the modifiers previously 
mentioned.  
ANOVA of the combined adult and child phantom (Group) data from the MiniCAT 
unit demonstrated no significant differences in effective dose between the adult and child 
controlling for Location (P = 0.2074 and 0.3577), and a marginal difference controlling for 
Basis Images (P= 0.0948 and 0. 0155). Also, no significant difference in effective dose was 
shown using ANOVA with the combined thyroid data selecting for Location (P = 0.3224 and 
0.2387) and Basis Images (P = 0.2972 and 0.1378). 
However, the ANOVA analysis of the data from the Accuitomo 170 demonstrated 
significant differences between the effective dose delivered to the adult and child (Group) 
and FOV (P=.0028 and 0.0008), Position (P = 0.0009 and < 0.0001), and Mode (P = .0019 
and 0.0002). Also, there was on average, a significant difference noted with the effective 
dose received by the thyroid tissue in the adult and child phantom depending on the FOV (P 
< 0.0001 and P = 0.0647), Position (P < 0.0001 and P < 0.0001), and Mode (P < 0.0001 and 
P = 0.0933).  
With the significant differences identified by ANOVA in the Accuitomo 170 data, the 
Tukey HSD test revealed only one factor that was different from other factors. The Tukey 
HSD test demonstrated that when the eight different FOVs were compared to determine their 
influence on effective dose, only the 140 x 100 mm and 60 x 60 mm proved to show a 
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significant difference. The comparison of the remaining different FOVs did not provide p 
values less than 0.05. 
Tables 10, 11, 12, and13 provide the equivalent doses to tissues and organs used in 
the calculation of effective dose for the MiniCAT and Accuitomo 170 units, respectively. 
Absorbed doses in the thyroid and brain were significantly greater in the child phantom than 
in the adult phantoms. The doses from both the MiniCAT and Accuitomo 170 were 
approximately two to three times higher in the child compared to the adult for the identical 
FOV and exposure protocol. 
Table 14 contains the average parameter values and standard deviations from the 
analysis of the QUART phantom images. Analysis with the QUART phantom for the 
Accuitomo 170 demonstrated that as the FOV increased from 60 x 60 mm to 80 x 80 mm and 
the exposure protocol was kept the same, the CNR average decreased approximately 20% 
(CNR 10.13 and 8.06 respectively). As the FOV enlarged to 100 x 100 mm and 140 x 100 
mm, the CNR average increased from 11.50 to 12.43, which is approximately a 10-20% 
increase from the beginning 60 x 60 mm FOV. Then finally, from 140 x 100 mm to 170 x 
120 mm FOV, the CNR average remained unchanged at 12.43. 
The average Modulation Transfer Function (MTF) 10% for the range of FOVs from 
60 x 60 mm to 170 x 120 mm showed no significant change in value (P > 0.05). This 
phenomenon of no significant difference was also demonstrated for the MTF 50% as the 
FOVs enlarged (P > 0.05). The average Nyquist frequency of the FOVs showed a trend to 
steadily decrease which was statistically significant with a P value of <.0001. 
The voxel size doubled from 125 µm to 250 µm as the FOV underwent multiple 
increases from 60 x 60 mm to 170 x 120 mm. The size doubling occurred at the FOV that 
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transitioned from the 80 x 80 mm to the 100 x 100 mm size. As expected, the CNR gradually 
improved but was statistically significant using the Least Squares Fit only for mAs when 
compared with voxel size and FOV width. The average MTF demonstrated no meaningful 
change with an increase in FOV from 60 x 60 mm to 170 x 120 mm. 
Discussion 
The Xoran MiniCAT is a compact, upright volume computed tomography system 
designed for high-resolution, bone window imaging of the sinuses, temporal bones, and skull 
base. MiniCAT provides immediate access to images at the patient’s point-of-care resulting 
in a faster diagnosis and treatment.33 The MiniCAT was first released to the commercial 
market in 2004. As was customary at the time, the unit has only standard imaging protocols 
available with very few options offered to customize the scan to the individual patient and 
particular needs of the prescribing doctor.  
Alternatively, the Accuitomo 170 CBCT unit is a more versatile imaging machine, 
which is also upright and compact. It has four imaging modes, nine field-of-view sizes, five 
resolution levels (125, 160, 200, or 250 µm), and zoom reconstruction to 80 µm voxel size. 
These features allow high-resolution imaging for just a few teeth, the sinuses, the 
temporomandibular joint TMJ, and to the entire head and neck area. Like other CBCT units, 
the Accuitomo 170 provides prompt access to the images and reconstruction software that 
permits curved MPR representations and 3D reconstruction. This machine has many more 
features, which is more typical of current production units designed for use in a wide variety 
of applications. 
In this study, ATOM phantoms and OSL dosimeters were employed based on their 
accuracy and procedural ease as validated in a recent publication by Ludlow et al.
26 
The use 
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of these standardized phantoms with consistent tissue equivalency and OSL dosimeters that 
can be read multiple times in minutes without loss of data, then expunged and reused, will 
allow the results of similar testing using other CBCT units to be reliably compared. 
Furthermore, the results of any study using ATOM phantoms and OSLs can be readily 
duplicated to verify the findings if desired. Last, because the report by Ludlow et al
26
 
indicated that the comparisons of thermoluminescent dosimeters (TLDs) and OSLs “yielded 
differences of less than 2% in the calculation of effective dose,” the results can also be 
equitably compared with data obtained with TLDs. 
Use of CBCT is greatly expanding in popularity, with many more practitioners 
purchasing units each year.  Use of these units will inevitably generate more images on an 
annual basis. Additionally, potential applications of these units are escalating beyond use as a 
diagnostic aid into a tool to fabricate surgical guides, mill restorations, and manufacture 
custom orthodontic appliances.
12 
The increased use has generated criticism regarding the 
potential impact on the patient population and in particular the pediatric subset of patients. 
Our results postulate that the overall average effective dose for the child phantom from the 
MiniCAT machine is 60% greater than the adult dose and 92% greater to the thyroid gland 
specifically. The Accuitomo 170 data reveals the average effective dose for the child 
phantom is 25% higher than the adult phantom and 116% greater to the thyroid gland of the 
child phantom when default programming is used.  When child settings are used the effective 
dose to the child is nearly equal to the adult phantom.  Clearly, there can be a notable and 
striking average increase in effective dose to the child phantom, but when you add in the fact 
that the radiosensitivity of the tissues in the pediatric patient is 2-5 times higher than the 
adult,
 16
 the risk of stochastic effects is further amplified. Use of a reduced mA setting can 
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reduce child doses by 40% (5 mA to 3 mA).  Because this is not the default setting for the 
unit, it is critically important for the prescribing practitioner and radiologic technician, or 
dental assistant in the dental setting, to know this information and apply the principles of 
ALARA when obtaining CBCT radiographic images on a pediatric patient. The application 
of this knowledge in a clinical setting entails selecting the smallest FOV necessary to capture 
the desired anatomy, using the child exposure settings if available on the unit, manually 
adjusting the exposure factors to account for the child versus the adult patient, decreasing the 
number of basis images obtained or allowing for a diminished resolution, selecting a 2D 
imaging technique, eliminating the radiographic exam altogether in favor of taking 
photographs, or obtaining the needed information in previous radiographs if available.  
It is imperative to understand why there are differences in the effective dose delivered 
to the adult and child phantoms. When the equivalent dose data for each organ position in the 
adult and child phantoms is analyzed, the increase in effective dose to the child is 
predominantly due to the dosimeters representing the thyroid gland site (Figure 22). The 
values calculated for thyroid dose in the adult ATOM phantom are based on readings from 
two dosimeters positioned at level 10. This location marks the site where the majority of the 
glandular tissue of both lobes and the thyroid isthmus is anatomically situated. The dosimeter 
positions in the child ATOM phantom are slightly different and are based on two dosimeters 
in level 9 averaged with one dosimeter positioned slightly higher in level 8. This alteration in 
position of the dosimeters in the two ATOM phantoms accounts for the minor but significant 
difference in propinquity of the thyroid gland to the inferior border of the mandible. The 
thyroid gland is closer to the lower border of the mandible in the child and, therefore, 
receives more direct exposure and scatter radiation when the base of the FOV is positioned 
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beneath the chin. Thyroid tissue was given a weighting factor value of .04 by the 2007 ICRP 
regulations and subsequently is responsible for sizable input when calculating effective dose 
to the head and neck during CBCT examinations.  
Unlike on ATOM phantoms, which are stiff and inflexible, actual patients in most 
cases can lift or rotate their chin superiorly, thereby creating a larger gap between the lower 
border of the mandible and the thyroid gland, which enables less of a direct exposure to the 
gland during imaging. This technique, which uses the rigid chin cup, is of limited value if the 
imaging will also be used for cephalometric analysis for orthodontic treatment or 
orthognathic surgery, due to the deformation of the soft tissue of the chin and cervico-mental 
region of the neck.  
The data from the phantoms also provides insight into how the effective dose is 
reduced when a smaller FOV is positioned in the region of the posterior maxilla. This is a 
particularly evident trend in the Accuitomo 170 data when comparing the effective dose 
between the maxillary posterior and the mandibular posterior for the 60 x 60 mm, 100 x 50 
mm, 140 x 50 mm, and 170 x 50 mm FOVs. Again, the distance away from the thyroid gland 
is the primary causation of this phenomenon (Figures 7, 8, and 9). 
In addition to the data regarding FOV dimension and the location of the FOV in the 
head and neck region, it is important to study the Tables 3–9 and identify the increase or 
reduction in effective dose delivered to the phantom based on the modifications in the 
exposure parameters of milli-amperage (mA), time (s), and the number of basis projections 
when the different modes are selected. The Accuitomo 170 unit, in particular, has the ability 
to choose between four different modes—High Speed, Standard, High Resolution, and High 
Fidelity. However, the MiniCAT only allows for some modification by offering a selection 
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of 150, 300, or 600 basis projections for the scan. The data for both machines illustrates an 
inclination toward an increase in effective dose when the modes above Standard (i.e., High 
Resolution and High Fidelity) are used with the Accuitomo 170 and above 150 basis images 
(i.e., 300 or 600 basis images) for the MiniCAT. This is due to the kVp being held constant 
for both machines (MiniCAT 120kVp, and 90 kVp for the Accuitomo) and only the time 
being increased. The increase in time (s) results in increased exposure which increases the 
dose to the patient. The MiniCAT data in Tables 3–6 indicates there was a direct linear 
relationship with the number of frames chosen for the scan and the dose to the phantom. 
These results are to be expected because a doubling of mAs (e.g. 12.08, 24.15, and 48.3) 
occurs concomitantly with a doubling of effective dose.  
Over the previous few years there has been an important and growing emphasis on 
lowering the dose of ionizing radiation used for diagnostic examinations. The “Image 
Gently” campaign was developed in 2007 and the focus of the alliance was to raise 
awareness of the opportunities to lower radiation dose in the imaging of children. The 
alliance website was launched in January 2014 and is an excellent resource for patients and 
practitioners, replete with guidelines for prescribing dental radiographs and links to position 
papers, an advisory statement from the American Dental Association (ADA), and the FDA 
recommendations. The main principles of justification and optimization are recommended 
for the protection of patients undergoing radiographic examinations. However, generous 
reductions in dose have to be balanced by maintaining adequate diagnostic image quality. 
There is an inevitable compromise between image quality and dose. There are very few, if 
any, published guidelines that correlate exposure parameters that will guarantee a very low 
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dose with a universally accepted superior diagnostic image. This is partly due to the 
subjective nature of the radiologist’s preference for image appearance.  
More research is needed to develop national standards for image quality acquisition. 
Germany is the first country to develop national standards for image quality testing of dental 
CBCT units.
26
 The QUART DVT test phantom was developed in Germany and is the first 
commercially available phantom that complies with those standards. The QUART DVT is a 
universal test phantom for quality assurance and quality control (QA/QC) for dental CBCT 
equipment. It has an automatic software evaluation program that evaluates Contrast, Noise, 
Homogeneity, MTF, Nyquist Frequency, and Contrast-to-Noise Ratio and complies with the 
European Commission on Radiological Protection No. 172.  
The QUART phantom was used in this study to evaluate the objective elements of 
image quality contrast-to-noise-ratio (CNR) and modulation transfer function (MTF) of the 
Accuitomo 170 (Table 14). The data obtained allowed for several patterns to be deduced. 
When the voxel size and FOV remain constant, an increase in CNR tends to occur with an 
increase in exposure (mAs). This process happens when there is a shift in basis images from 
250 to 500 or an alteration in time (s) when transitioning between High Speed, Standard, 
High Resolution, and High Fidelity modes. Adjustments in CNR have been shown to be 
associated with perception of image quality change by observers.
42
 When CNR increases, the 
overall quality of the image is more visually appealing. Reductions in voxel size or increases 
in FOV would be expected to decrease CNR if other technical parameters are constant.  This 
trend was not statistically significantly with the Accuitomo 170. As the FOV becomes larger, 
there is often an automatic increase in voxel size (125, 160, 250 µm) that compensates for the 
reduction in CNR that would be expected to follow.  
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Analysis of the MTF 10% and MTF 50% data did not identify any statistically 
significant deviations that could be associated with variations to voxel size. However, the 
Nyquist frequency did reflect a small, gradual, steady reduction as the voxel size and FOV 
increased. At this point, only basic, fundamental tendencies are identified using the QUART 
phantom with the Accuitomo 170. Further research will be required to correlate quantitative 
measures and individual preferences for image quality with diagnostic efficacy.  
It is beyond the scope of this paper to present a thorough review of the literature 
regarding thyroid cancer trends in the United States. However, commonly exposed to 
radiation by CBCT radiography for dental imaging.  A February 2014 article published in 
JAMA Otolaryngology, Head and Neck 
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 notes that since 1975 the incidence of thyroid 
cancer has nearly tripled, from 4.9 to 14.3 per 100,000 individuals. The absolute increase was 
almost four times greater in women than men. No information regarding etiology was 
mentioned in the article. The increased incidence has been labeled an epidemic of diagnosis 
rather than disease. The mortality rate has remained stable because much of the diagnosed 
thyroid cancer is the papillary type, which has a very low incidence of mortality. This is an 
example of improved diagnostic technology, including radiographic imaging, leading to the 
ability of distinguishing more disease. Not all lesions, especially in older adults, may require 
treatment. 
Other studies have noted a correlation between exposure to dental x-rays and 
increased risk of thyroid cancer. Study design weaknesses, small sample sizes, and long 
periods between exposure and cancer detection make it difficult to link exposure to 
causation.
44 
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Yuri Nikiforov reported on a cohort of children exposed to radiation from the 
Chernobyl nuclear power plant accident.  4000 children and adolescents with thyroid cancer 
demonstrated an increased risk of thyroid cancer that was dose-dependent.
34
 The youngest 
children are the most sensitive to radiation-induced carcinogenesis, and the minimal latent 
period for thyroid cancer development after exposure was 4 years. The risk of radiation-
induced thyroid cancer development is also age-dependent and greatest at age 1, with a 237- 
fold increase. However, there is still a significant six-fold increase in children aged 10.
34  
The 
malignant tumors that have resulted are commonly well differentiated histologically, 
progress slowly, and can be managed successfully with surgical excision or treated with 
radioactive iodine in the case of metastasis. It is estimated that approximately 5% of the 
radiation induced thyroid cancers result in mortality.
35 
 
Conclusion 
A wide range of imaging options are available to the user of CBCT. A thorough 
understanding of the technical parameters that are available in the particular machine that is 
used is important for a balance of diagnostic quality and patient dose. Because of their 
increased sensitivity to radiation, particular attention should be given to adjusting exposures 
for children. When at all possible, the smallest field-of-view capturing only the required 
anatomic structures, the lowest exposure settings, consistent with the diagnostic task will 
help comply with the “One size does not fit all… so when we image, let’s image gently!” 
mantra from the Image Gently campaign.  More selection criteria are becoming available as 
the ADA and dental specialty organizations are partnering with the American Academy of 
Oral and Maxillofacial Radiology to recommend imaging guidelines. Further research with 
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QUART phantom type instruments will allow the development of improved universal 
parameters for optimization of contrast-to-noise ratio and modulation-transfer-function.  
The articles cited in this study regarding the thyroid gland shed some light on the 
issues of thyroid cancer that still need further investigation. Nevertheless, there is agreement 
that thyroid cancer can be caused by low-dose radiation, children have an increased 
radiosensivity and are a vulnerable subset, and close surveillance is necessary because of the 
known short duration time in which malignant lesions can develop. Being a responsible 
steward of radiology and respecting the power of ionizing radiation will benefit both the 
patient and practitioner alike.   
66 
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APPENDIX. FIGURES AND TABLES 
Figure 1. CT procedures per year in the United States 
 
 
 
Figure 2. Source of per capita contribution of of radiation exposure in the United States 
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Figure 3. A. Optically Stimulated Luminescent (OSL) dosimeters. B. Microstar Reader 
 
 
 
Figure 4. MiniCAT CBCT and viewing station (Xoran Technologies, Ann Arbor, MI) 
  
 Courtesy of Xoran Technology Sales and Marketing Brochure  
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Figure 5. MiniCAT fields of view (Courtesy of Xoran Technology Sales and Marketing 
Brochure) 
 Sinus and Maxillofacial 16 x 13 cm 
   
 
Temporal Bone 16 x 6.5 cm 
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Figure 6. Protocols per manufacturer 
 
Courtesy of Xoran Technology Sales and Marketing Brochure 
 
 
Figure 7. Accuitomo 170, J. Morita Corporation  
 
Courtesy of J. Morita Corporation Sales and Marketing Brochure   
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Figure 8. Accuitomo 170: Nine fields of view 
 
Courtesy of J. Morita Corporation Product Brochure  
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Figure 9. Accuitomo 170 acquisition parameters 
 
Courtesy of J. Morita Corporation Product Brochure 
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Figure 10. Adult ATOM Phantom slices with machined slots for OSL dosimeters 
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Figure 11. Locations of Optically Stimulated Luminescent (OSL) dosimeters in Adult ATOM 
Max model 711 Phantom. 
OSL 
ID 
Level of OSLD location 
 
Phantom Levels 
 
1 Calvarium anterior (2) 
2 Mid brain (2) 
3 Calvarium left (3) 
4 Mid brain (3) 
5 Calvarium posterior (4) 
6 Pituitary (4) 
7 Right lens of eye (4-5) 
8 Left lens of eye (4-5) 
9 Right ethmoid (5 
10 Left maxillary sinus (6) 
11 Oropharyngeal airway (7) 
12 Right parotid (7) 
13 Left parotid (7) 
14 Right ramus (7) 
15 Left ramus (7) 
16 Left back of neck (8) 
17 Right submandibular gland (8) 
18 Left submandibular gland (8) 
19 Center sublingual gland (8) 
20 Center C spine (8) 
21 Lateral neck - left (9) 
22 Thyroid – left (10) 
23 Thyroid - right (10) 
24 Esophagus (10) 
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Figure 12A. Child ATOM Phantom with OSL dosimeter locations 
 
OSL 
ID No. 
Child Phantom Location 
(level of OSLD location) 
 
Phantom Levels 
 
 
1 Calvarium anterior (2) 
2 Calvarium left (2) 
3 Calvarium posterior (2) 
4 Mid brain (2) 
5 Mid brain (3) 
6 Pituitary (4) 
7 Right orbit (4) 
8 Right lens of eye (4-5) 
9 Left lens of eye (4-5) 
10 Right maxillary sinus (5) 
11 Left nasal airway (5) 
12 Right parotid (6) 
13 Left parotid (6) 
14 Left back of neck (6) 
15 Right ramus (7) 
16 Left ramus (7) 
17 Right submandibular gland (7) 
18 Left submandibular gland (7) 
19 Center sublingual gland (7) 
20 Center C spine (8) 
21 Thyroid superior–left (8) 
22 Thyroid – left (9) 
23 Thyroid - right (9) 
24 
Esophagus (9) 
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Figure 12B. Child ATOM Slices with machined OSL dosimeter locations  
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Figure 13. Field of view examples acquired from Xoran MiniCAT volumes  
Child 16 x 13 cm Maxillofacial (MF) 300 
 
Child 16 x 13 cm MF 600 
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Child 16 x 13 cm Sinus 300 
  
Child 16 x 13 cm Sinus 600 
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Child 16 x 6.5 cm T-bone 
 
 
 
Figure 14. Examples of representative FOVs from the Accuitomo 170; adult and child 
Adult 10 x 10 cm  
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Adult 14 x 10 cm 
 
 
Adult 17 x 12 cm 
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Child 10 x 10 cm 
 
Child 14 x 10 cm 
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Child 17 x 12 cm 
 
 
 
Figure 15. QUART DVT_AP CBCT image quality system: A, phantom; B, sample axial 
images of polyvinyl chloride and air elements (top) and acrylic plastic layer (bottom); C, 
analysis software window for calculation of the Nyquist frequency; D, analysis software 
window for calculating homogeneity. 
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Figure 16. Graphic representation of effective dose using the MiniCAT and ATOM Phantom  
 
 
 
Figure 17. Effective doses for thyroid gland in adult and child ATOM Phantom 
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Figure 18. MiniCAT—% increase in thyroid effective dose between adult and child Phantom 
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 Figure 19. Accuitomo 170 effective dose for adult and child ATOM Phantom 
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Figure 20. Accuitomo 170 effective dose for thyroid using the adult and child ATOM 
Phantom. 
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Figure 22. Comparison of thyroid level in child and adult. The red line denotes the lower 
edge of the volume. 
 
 
 Table 1.  
ICRP Tissue-Weighting Factors (WT) (ICRP 1977; ICRP 1990; ICRP 2007) 
ICRP REPORT ICRP 26 ICRP 60  ICRP 103 ICRP 26 ICRP 60 ICRP 103 
YEAR   1977 1990 2007 Tissues Included in Remainder Tissues 
Quantity   EDE ED ED --- --- Adipose Tissue 
Tissue   Tissue Weighting Factors, WT --- Adrenals Adrenals 
Gonads   0.25 0.2 0.08 --- Brain STWF 
Breast   0.15 0.05 0.12 --- --- Connective Tissue 
Red bone marrow 0.12 0.12 0.12 --- --- Extrathoracic airways 
Lung   0.12 0.12 0.12 --- --- Gall bladder 
Thyroid   0.03 0.05 0.04 --- Brain IMT 
Bone surfaces 0.03 0.01 0.01 --- --- Heart wall 
Colon   --- 0.12 0.12 --- Kidney Kidney 
Stomach   --- 0.12 0.12 --- --- Lymph nodes 
Bladder   --- 0.05 0.04 --- Muscle Muscle 
Esophagus --- 0.05 0.04 Liver STWF STWF 
Liver   --- 0.05 0.04 LLI STWF STWF 
Brain   --- --- 0.01 --- --- Pancreas 
Salivary Glands --- --- 0.01 --- --- Prostate 
Skin   --- 0.01 0.01 SG --- IMT 
*Remainder 
Tissues --- 0.05 0.12 SI SI SI wall 
Total   1.0 1.0 1.0 Stomach STWF STWF 
    
  --- Spleen Spleen 
    
  --- --- Thymus 
    
  ULI ULI STWF 
        
9
2
 
 *Tissues selected to represent the remainder in ICRP reports 26, 60, and 103 are shown on the right side of the table.  
EDE, Effective Dose Equivalent (HE), ED, Effective Dose (E); STWF, See Tissue Weighting Factor Table; LLI, lower large 
intestine; SG, salivary glands; SI, small intestine; ULI, upper large intestine. 
  ICRP 26: ICRP Publication 26, Recommendations of the International Commission on Radiological Protection,  
Pergamon Press, Oxford, England (1977). 
    ICRP 60: International Commission on Radiological Protection. 1990 Recommendations of the International Commission 
on Radiological Protection, ICRP Publication 60, Ann.ICRP 21(1-3) (Elsevier, New York), (1991). 
 
ICRP 103: The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 
103. Ann.ICRP 37(1-32) (2007). 
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Table 2.  
Estimated Percentage of Tissue irradiated and OSLs Used to Calculate Mean Absorbed Dose 
to a Tissue or Organ of an Adult or 10-Year-Old Child ATOM Phantom 
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Table 3.  
MiniCAT: Effective Dose Adult and Child ATOM Phantom  
 
 
Table 4.  
 
MiniCAT: Effective Dose with Percentage Increase from Adult to Child 
 
Phantom FOV location mAs  Effective 
Dose (µSv) 
2007 
% Increase 
Child 16x13 sinus 48.3 148  66 
Child 16x13 sinus 24.2 79 71 
Child 16x13 sinus 12.1 38 65 
Child 16x13 maxillofacial 48.3 251 45 
Child 16x13 maxillofacial 24.2 124 45 
Child 16x13 maxillofacial 12.1 62 44 
Child 16x6.5 Temporal 58.8 123 89 
Average    117 60.7 avg. 
 
Table 5.  
MiniCAT: Thyroid Effective Dose Adult and Child ATOM Phantom 
 
  
MiniCAT Effective Dose
FOV(cm) Location      Frames Adult (µSv) Child (µSv)
16 x 13 Sinus 150 23 38
16 x 13 Sinus 300 46 79
16 x 13 Sinus 600 89 148
16 x 13 Maxillofacial 150 43 62
16 x 13 Maxillofacial 300 85 124
16 x 13 Maxillofacial 600 173 251
16 x 6.5 Temporal 600 65 123
Thyroid Effective Dose
FOV(cm) Location Frames Adult (µSv) Child (µSv)
16 x 13 Sinus 300 5.8 11
16 x 13 Sinus 600 13.3 21.4
16 x 13 Maxillofacial 300 20.9 46.2
16 x 13 Maxillofacial 600 45.3 100
16 x 6.5 Temporal 600 11.1 19
97 
Table 6.  
MiniCAT Thyroid Effective Dose 
 
 
Table 7.  
Accuitomo 170 Adult and Child Effective Dose 
 
  
Thyroid Effective Dose
FOV(cm) Location Frames Adult (µSv) Child (µSv) % Increase
16 x 13 Sinus 300 5.8 11 90
16 x 13 Sinus 600 13.3 21.4 61
16 x 13 Maxillofacial 300 20.9 46.2 120
16 x 13 Maxillofacial 600 45.3 100 120
16 x 6.5 Temporal 600 11.1 19 71
Accuitomo 170 Adult and Child Effective Dose (µSv)
Field of View position Mode ED Adult ED Child
60 x H 60 mm max posterior High Resolution 360 114 180
60 x H 60 mm max anterior High Resolution 360 109 265
60 x H 60 mm mand posterior High Resolution 180 148 257
60 x H 60 mm mand posterior Standard 360 158 227
60 x H 60 mm mand posterior High Resolution 360 239 336
60 x H 60 mm mand posterior High Fidelity 360 252 375
100 x H 50 mm mand arch High Fidelity 360 297 519
100 x H 50 mm max arch High Fidelity 360 198 198
80 x H 80 mm full arch High Fidelity 360 160 439
140 x H 50 mm mand arch High Fidelity 360 461 521
140 x H 50 mm max arch High Fidelity 360 240 290
170 x H 50 mm mand arch High Fidelity 360 414 582
170 x H 50 mm max arch High Fidelity 360 232 312
100 x H 100 mmfull arch High Fidelity 360 453 548
140 x H 100 mmfull arch High Fidelity 360 473 626
170 x H 120 mmfull arch Standard 180 154 212
170 x H 120 mmfull arch High Fidelity 180 260 353
170 x H 120 mmfull arch Standard 360 325 430
170 x H 120 mmfull arch High Fidelity 360 532 769
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Table 8.  
Accuitomo 170 Adult and Child Thyroid Effective Dose 
 
  
Accuitomo 170 Adult and Child Thyroid Effective Dose (µSv)
Field of View position Mode Adult Child
60 x H 60 mm max posterior High Resolution 360 10 24
60 x H 60 mm max anterior High Resolution 360 12 73
60 x H 60 mm mand posterior High Resolution 180 23 94
60 x H 60 mm mand posterior Standard 360 30 62
60 x H 60 mm mand posterior High Resolution 360 42 93
60 x H 60 mm mand posterior High Fidelity 360 48 123
100 x H 50 mm mand arch High Fidelity 360 86 238
100 x H 50 mm max arch High Fidelity 360 18 30
80 x H 80 mm full arch High Fidelity 360 72 160
140 x H 50 mm mand arch High Fidelity 360 86 236
140 x H 50 mm max arch High Fidelity 360 21 40
170 x H 50 mm mand arch High Fidelity 360 97 234
170 x H 50 mm max arch High Fidelity 360 21 40
100 x H 100 mmfull arch High Fidelity 360 105 197
140 x H 100 mmfull arch High Fidelity 360 97 211
170 x H 120 mmfull arch Standard 180 32 83
170 x H 120 mmfull arch High Fidelity 180 47 134
170 x H 120 mmfull arch Standard 360 73 171
170 x H 120 mmfull arch High Fidelity 360 137 312
99 
Table 9. 
Accuitomo 170 Percent Thyroid Contribution to Effective Dose 
 
 
Accuitom 170 Percent Thyroid Contribution to Effective Dose
Field of View position Mode Adult Child
60 x H 60 mm max.      post. High Resolution 360 9 13
60 x H 60 mm max.      ant. High Resolution 360 11 27
60 x H 60 mm mand.      post. High Resolution 180 16 36
60 x H 60 mm mand.       post. Standard 360 19 27
60 x H 60 mm mand.      post. High Resolution 360 18 28
60 x H 60 mm mand.       post. High Fidelity 360 19 33
100 x H 50 mm mand.      arch. High Fidelity 360 29 46
100 x H 50 mm max.        arch High Fidelity 360 9 15
80 x H 80 mm full         arch High Fidelity 360 20 36
140 x H 50 mm mand.        arch High Fidelity 360 13 45
140 x H 50 mm max.          arch High Fidelity 360 9 14
170 x H 50 mm mand.           arch High Fidelity 360 23 40
170 x H 50 mm max.        arch High Fidelity 360 9 13
100 x H 100 mmfull          arch High Fidelity 360 23 36
140 x H 100 mmfull          arch High Fidelity 360 20 34
170 x H 120 mmfull           arch Standard 180 20 39
170 x H 120 mmfull            arch High Fidelity 180 18 38
170 x H 120 mmfull          arch Standard 360 23 40
170 x H 120 mmfull           arch High Fidelity 360 26 41
 Table 10.  
Equivalent Dose Measurements on the Adult Phantom for MiniCAT 
Equivalent Dose Measurements (µGy) on an Adult Phantom for the MiniCAT by FOV, Region of Interest, and Scanning Protocol 
Weighted Components of 
Tissue 
Sinus/16x13/300 Sinus/ 16x13/600 MF/ 16x13/300 MF/16x13/600 T-
bone/16x6.5/600 
Bone Marrow 112.493 213.7489 76.33277 155.793 137.3069 
thyroid 145.4574 282.9178 521.2967 1131.358 277.7892 
esophagus 16.08606 33.23425 56.82331 133.7581 32.1358 
skin 71.02953 144.5316 74.26102 141.6211 123.5193 
bone surface 324.5674 614.8843 172.9473 347.0661 343.1474 
Salivary glands 675.5224 1303.472 1814.688 3550.955 931.3161 
brain* 16.08606 33.23425 56.82331 133.7581 32.1358 
remainder      
 brain† 1270.186 2390.334 363.449 594.7772 1775.606 
 lymphatic nodes* 28.79024 55.67756 71.42582 142.3581 39.25069 
 extrathoracic airway* 759.9883 1489.69 1439.266 2856.696 1231.576 
 muscle*† 24.21957 46.86615 69.7086 138.5705 35.04366 
 oral mucosa* 843.3961 1623.837 1796.045 3522.505 1087.316 
 
  
9
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 Table 11.  
Equivalent Dose Measurements on the Child Phantom for MiniCAT  
 
Equivalent Dose Measurements (µGy) on the Child Phantom for the MiniCAT by FOV, Region of Interest, and the Scanning Protocol 
Weighted Components of 
Tissue 
Sinus/16x13/300 Sinus/ 16x13/600 MF/ 16x13/300 MF/16x13/600 T-
bone/16x6.5/600 
Bone Marrow  124.6075 155.4915 83.91272 155.4915 103.791 
thyroid   275.5774 2500.594 1155.5 2500.594 474.5707 
esophagus  19.73406 194.0439 77.58489 194.0439 36.44209 
skin   98.27294 160.3635 78.73542 160.3635 190.138 
bone surface  257.4576 361.6585 195.1323 361.6585 196.5094 
Salivary glands  1231.101 3794.656 1953.641 3794.656 2098.297 
brain*   1334.22 1271.058 682.5152 1271.058 2248.595 
remainder       
 brain†   1334.22 1271.058 682.5152 1271.058 2248.595 
 lymphatic nodes*  40.66065 156.5667 77.65808 156.5667 73.96483 
 extrathoracic airway* 1125.789 3363.507 1703.342 3363.507 2188.424 
 muscle*†  40.66065 156.5667 77.65808 156.5667 73.96483 
 oral mucosa*  1258.969 3747.956 1947.221 3747.956 2305.107 
  
1
0
0
 
 Table 12.  
Equivalent dose Measurements on an Adult Phantom for the Accuitomo 170 
  
  
Equivalent Dose Measurements (µGy) on an Adult Phantom for the Accuitomo 170 by FOV, Region of Interest, and Scanning Protocol
Weighted Components of Tissue 10
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thyroid 2636 2141 438 2415 2158 526 1174 3435 786 1831 2418 524 1198 579 288 1143 1053 246 745 1620
esophagus 246 197 48 264 224 61 136 327 90 200 268 63 115 63 32 96 105 26 75 150
skin 268 73 180 301 113 186 170 441 96 295 110 149 66 57 189 63 65 138 44 181
bone surface 1463 518 1176 1579 1426 1349 920 1633 507 1052 1087 1269 796 569 572 611 789 574 514 986
Salivary glands 9657 7403 3433 10316 11199 4360 5293 10284 3146 6545 9748 4315 5315 2817 1981 4953 4848 1880 3150 7492
brain 311 76 258 515 129 354 726 785 350 549 115 361 76 60 182 63 86 217 55 145
remainder 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
   lymphatic nodes* 419 264 212 453 464 260 257 464 149 293 395 253 272 166 112 205 265 124 173 304
   extrathoracic airway* 7405 4556 3786 8038 8013 4628 4677 9065 2704 5752 6807 4465 4694 2876 2123 3547 4593 2649 2984 5292
   muscle* 419 264 212 453 464 260 257 464 149 293 395 253 272 166 112 205 265 124 173 304
   oral mucosa* 9505 6281 4540 10349 10852 5689 5974 10456 3458 6648 9204 5561 6469 3912 2463 4764 6341 2815 4110 7005
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 Table 13.  
Equivalent Dose Measurements on a Child Phantom for the Accuitomo 170 
 
  
Equivalent Dose Measurements (µGy) on an Child Phantom for the Accuitomo 170 by FOV, Region of Interest, and Scanning Protocol
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Bone Marrow 265 265 77 367 329 114 220 426 129 244 345 135 186 122 118 170 66 71 108 206
thyroid 4936 5952 744 5267 5907 1000 3339 7788 2079 4265 5853 1012 3074 2338 1815 2333 603 1257 1549 3994
esophagus 175 188 45 201 224 65 164 478 99 253 200 68 119 81 74 101 37 46 72 131
skin 623 106 402 562 123 431 178 534 104 307 163 312 92 85 86 96 353 34 68 176
bone surface 1020 1040 287 1415 1301 429 846 1641 501 940 1361 508 728 479 456 660 243 276 419 799
Salivary glands 10096 8841 5259 11334 8311 7785 5568 11788 3252 6622 10450 8755 8190 5022 6816 8143 4540 2954 5558 8840
brain 2009 224 625 2979 250 993 1743 3467 981 2039 328 893 255 153 240 272 934 94 202 570
remainder 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
   lymphatic nodes* 365 335 160 417 330 244 233 487 139 273 401 272 284 193 205 264 148 104 181 305
   extrathoracic airway* 8322 6316 4363 9370 6199 6270 4683 10137 2760 5752 7733 6468 5590 3755 4161 5267 4120 2022 3628 6809
   muscle* 365 335 160 417 330 244 233 487 139 273 401 272 284 193 205 264 148 104 181 305
   oral mucosa* 9826 8117 5222 11454 7898 8063 6059 11917 3553 6760 10515 9033 8141 5379 6155 7902 4876 2894 5440 8308
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 Table 14.  
Quart Data for the Accuitomo 170 
 
Technique Voxel mAs
FOV 
width Rotation
PMMA 
voxel
PMMA 
Noise
Homoge
neity Contrast CNR MTF 10% MTF 50%
Nyquist 
Frequen
cy
Quart 60x60 HiFi 180 5mA 125u 125 79 6 180 1941.86 62.88 18.33 650.65 11.46 1.73 0.36 3.95
Quart 60x60 HiFi 360 5mA 125u 125 154 6 360 1251.83 43.51 24.67 659.79 16.54 1.73 0.87 3.95
Quart 60x60 HiRes 180 5mA 
125u 125 79 6 180 2103.61 114.06 52.33 660.93 6.52 2.34 1.01 3.95
Quart 60x60 HiRes 360 5mA 
125u 125 154 6 360 1583.33 79.97 92.33 647.00 8.92 2.32 1.08 3.95
Quart 60x60 HiSpeed 180 5mA 
125u 125 27 6 180 1876.02 107.63 35.67 564.69 6.68 1.56 0.76 3.95
Quart 60x60 HiSpeed 360 5mA 
125u 125 53 6 360 1299.79 77.44 34.00 665.96 9.40 1.70 0.83 3.95
Quart 60x60 Std. 180 5mA 125u 125 45 6 180 2034.93 79.88 18.00 658.62 8.63 1.63 0.89 3.95
Quart 60x60 Std. 360 5mA 125u 125 88 6 360 1330.51 57.74 24.00 654.26 12.86 1.81 0.78 3.95
Quart 80x80 HiFi 180 5mA 160u 160 79 8 180 2264.04 82.77 21.67 444.54 7.69 2.47 0.94 3.08
Quart 80x80 HiFi 360 5mA 160u 160 154 8 360 1904.64 59.78 21.33 575.38 10.89 2.40 1.02 3.10
Quart 80x80 Std. 180 5mA 160u 160 45 8 180 2390.65 110.20 18.00 550.30 6.50 2.34 1.04 3.10
Quart 80x80 Std. 360 5mA 160u 160 88 8 360 1898.02 78.73 22.00 547.63 7.17 2.52 0.86 3.10
Quart 100x100 HiFi 180 5mA 
250u 250 79 10 180 2506.39 57.21 21.00 549.32 10.03 1.85 0.90 2.00
Quart 100x100 HiFi 360 5mA 
250u 250 154 10 360 1497.99 41.28 21.00 534.52 14.63 1.69 0.82 2.00
Quart 100x100 Std. 180 5mA 
250u 250 45 10 180 3311.62 77.59 23.00 611.04 9.20 1.94 0.74 2.00
Quart 100x100 Std. 360 5mA 
250u 250 88 10 360 1636.61 56.11 23.00 594.45 12.14 1.97 0.72 2.00
Quart 140x100 HiFi 180 5mA 
250u 250 79 14 180 4131.94 55.14 35.00 563.64 13.79 1.95 0.86 1.95
Quart 140x100 HiFi 360 5mA 
250u 250 154 14 360 1410.13 39.99 30.00 518.05 16.04 1.79 0.88 2.00
Quart 140x100 Std. 180 5mA 
250u 250 45 14 180 4766.35 76.26 27.00 553.03 7.47 1.92 0.83 2.00
Quart 140x100 Std. 360 5mA 
250u 250 88 14 360 1545.25 53.58 31.00 551.48 12.41 1.74 0.83 2.00
Quart 170x120 HiFi 180 5mA 
250u 250 79 17 180 3251.62 58.00 61.33 616.78 12.80 1.71 0.81 1.95
Quart 170x120 HiFi 360 3mA 
250u 250 92 17 360 2247.92 55.10 82.00 573.64 10.83 1.87 0.80 1.95
Quart 170x120 HiFi 360 5mA 
250u 250 154 17 360 1732.01 41.13 70.00 600.90 13.96 1.74 0.80 1.95
Quart 170x120 HiFi 360 7mA 
250u 250 216 17 360 1667.35 35.22 89.00 591.69 20.51 1.80 0.79 1.95
Quart 170x120 Std. 180 5mA 
250u 250 45 17 180 4026.44 79.37 47.00 548.68 7.18 1.95 0.80 1.95
Quart 170x120 Std. 360 3mA 
250u 250 53 17 360 2091.15 70.79 71.00 588.63 7.66 1.95 0.70 1.95
Quart 170x120 Std. 360 5mA 
250u 250 88 17 360 1863.41 53.67 71.33 623.25 11.76 1.70 0.80 1.95
Quart 170x120 Std. 360 7mA 
250u 250 123 17 360 1766.40 46.35 92.67 620.80 14.82 1.92 0.84 2.00
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Table 15.  
Accuitomo 170: Parameters of Time (s) and Frames Per Scan 
 
Accuitomo 170 time (s) Frames µsec/frame 
Standard 180 9 250 36 
Standard 360 17.5 500 35 
High Resolution 180 15.8 250 63.2 
High Resolution 360 30.8 500 61.6 
High Fidelity 180 15.8 500 31.6 
High Fidelity 360 30.8 1000 30.8 
High Speed 180 5.4 250 21.6 
High Speed 360 10.5 500 21 
 
 
